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Abstract: Cytokine, welche zur Superfamilie der Tumor Nekrosis Faktoren (TNF) gehören, sind im
Menschen in zahlreiche physiologische und pathologische Prozesse, wie zum Beispiel Entzüdungsreak-
tionen, Autoimmunkrankheiten, Krebs oder Diabetes, involviert. In Säugern ist die Erforschung von
TNF-Signalmechanismen durch das Vorhandensein von mehreren Liganden und Rezeptoren und min-
destens drei intrazellulär induzierten Signalwegen (NF￿B, JNK, Caspase-8) erschwert. Im Genom von
Drosophila melanogaster ist nur ein einziges TNF Homolog (Eiger) codiert, was es erlaubt, nun auch
genetische Methoden zur Entdeckung neuer Komponenten anzuwenden. Überexpression von Eiger im
Facettenauge von Drosophila löst lokale JNK-induzierte Apoptose aus, was zu einem dramatischen Ver-
lust von Augengewebe führt. Dieser ”Kleine-Augen-Phänotyp” war die Basis für die Entwicklung eines
Screeningsystems zur Isolation dominanter Suppressoren dieses Signalweges. Die Tatsache, dass Gene
wie dTAB2 in diesem Screen identifziert wurden, deutet darauf hin, dass gewisse Aspekte des TNF-
Signalmechanismus zwischen Fliege und Mensch konserviert sind. Die Charakterisierung weiterer Sup-
pressoren ist ein wichtiger Schritt in der Entschlüsselung dieses evolutionär konservierten Signalweges
und könnte auch wichtige Hinweise zur Entwicklung neuer Medikamente liefern. In humans tumor necro-
sis factor (TNF) plays important roles in several physiological as well as pathological processes, such
as haematopoiesis, inflammation, diabetes, cancer or autoimmune disorders. Binding of TNF ligands
to their receptors can lead to the activation of NF￿B (nuclear factor kappa B), JNK (c-Jun-N-terminal
kinase) and Caspase-8. In contrast to the high number of TNF ligands and receptors encoded in the
human genome, the Drosophila genome encodes for a single TNF homolog called Eiger, offering the
possibility of applying genetic approaches to dissect the molecular mechanisms of TNF/Eiger-signaling.
Over-expression of Eiger in the compound eye leads to JNK-mediated induction of apoptosis, resulting
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indicate an evolutionarily conserved mechanism of TNF-induced JNK activation, proving that Drosophila
is a suitable model to study the molecular mechanisms of TNF signaling. The characterization of the
remaining suppressor mutations may uncover further important aspects of this evolutionarily ancient
signaling pathway and possibly reveal new drug targets for diseases where TNF signaling is misregulated.
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RIP receptor-interacting protein
TAB2/3 TAK1 binding protein 2/3
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Zusammenfassung 1
1  Zusammenfassung
Cytokine, welche zur Superfamilie der Tumor Nekrosis Faktoren (TNF) gehören, sind im
Menschen in zahlreichen physiologischen und pathologischen Prozessen involviert. Daher
sind die TNF Signalmechansimen und die dadurch ausgelösten zellulären Antworten von
hohem Interesse für die Forschung. Mehr als 30 Jahre intensiver Forschung haben ein
Netzwerk von Signalwegen und zellulären Antworten hervorgebracht, welche durch TNF
Liganden induziert werden. Um diesen komplexen Signalweg und seine Mitwirkung bei der
Entstehung von TNF assozierten Krankheiten besser zu verstehen, ist es äusserst wichtig,
alle Signal-komponenten und Regulatoren dieses Signalweges zu identifizieren. In Säugern
ist die Erforschung von TNF-Signalmechansimen durch das Vorhandensein von mehreren
Liganden und Rezeptoren und mindestens drei intrazellulär induzierten Signalwegen
erschwert. Bis anhin wurden neue Komponenten vor allem mittels biochemischen Methoden
oder Homologien zu bereits bekannten Komponenten identifiziert. Im Genom von Drosophila
melanogaster ist nur ein einziges TNF Homolog (Eiger) codiert, was es erlaubt, nun auch
genetische Methoden zur Entdeckung neuer Komponenten anzuwenden.
In Säugern werden durch TNF vor allem der NFB (nuclear factor kappa B)-, JNK (c-Jun-N-
terminal kinase)- und Caspase-8-Signalweg aktiviert, was zu verschiedensten Antworten wie
Proliferation, Differenzierung, Überleben und Apoptose führen kann. Überexpression von
Eiger im Facettenauge von Drosophila melanogaster löst lokale JNK-induzierte Apoptose
aus, was zu einem dramatischen Verlust von Augengewebe führt. Dieser “Kleine-Augen-
Phänotyp” war die Basis für die Entwicklung eines Testsystems zur Isolation dominanter
Suppressoren dieser Aktivität. Zu diesem Zweck wurde ein Mutagenese-Screen durchgeführt,
wobei über 100 Mutationen isoliert wurden, welche dominant den Eiger-JNK-Signalweg
schwächen. Wie erwartet betreffen einige dieser Mutationen bereits bekannte Komponenten.
Es wurden aber auch Mutationen in den Genen dTAB2, Mkk4 und lilliputian gefunden, deren
Genprodukte noch nicht mit dem Eiger-Signalweg assoziiert waren.
Wir konnten zeigen, dass dTAB2 eine Adaptorfunktion hat, welche die Rezeptorkomplex-
Komponente dTRAF1 mit einer der aktiven Schlüsselkomponeneten dTAK1 verbindet. Dies
demonstriert auch, dass die Funktion von TAB Proteinen von der Fliege bis zum Menschen
konserviert ist. Unsere Experimente haben weiter gezeigt, dass, im Gegensatz zu Säugern, in
Drosophila beide JNK aktivierenden Kinasen, Hemipterous (dMkk7) und Mkk4, für die TNF-
induzierte Aktivierung von JNK benötigt werden. Ob im Menschen ein dem Protein Lilliputian
ähnlicher Transkriptionsfaktor ebenfalls in Kooperation mit AP-1 das TNF Signal transduziert,
wie das unsere Experimente in Drosophila andeuten, bleibt zu erforschen.
Das Klonieren weiterer Suppressoren und die Charakterisierung deren Genprodukte ist ein
wichtiger Schritt in der Entschlüsselung dieses evolutionär konservierten Signalweges, was
möglicherweise auch zur Entwicklung neuer Medikamente für die Behandlung von Auto-
immunkrankheiten, Krebs und Diabetes führen kann.
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2  Summary
Cytokines of the tumor necrosis factor (TNF) superfamily are involved in a vast number of
physiological and pathological processes in humans. The signaling mechanisms and cellular
outputs induced by TNF ligands are therefore of high interest, which is reflected by the
immense amount of research performed in this area. Over 30 years of intensive studies has
revealed a network of signaling pathways and cellular responses that are induced by TNF. To
understand this complex signaling pathway, and its contribution to the development of
diseases where TNF signaling is deregulated, it is important to identify all the regulators and
transduction components. The study of TNF signaling mechanisms in mammalian systems is
complicated by the existence of numerous ligands and receptors and at least three different
intracellular signaling pathways. So far new components were mainly isolated by biochemical
or homology search approaches. The identification of a single TNF family member, Eiger, in
the genome of Drosophila melanogaster, offers the possibility to apply genetic approaches for
pursuing this goal.
In mammals TNF mainly induces the NFB (nuclear factor kappa B), JNK (c-Jun-N-terminal
kinase) and caspase-8 pathways, leading to responses as diverse as proliferation,
differentiation, survival and apoptosis. When overexpressed in the compound eye of
Drosophila melanogaster Eiger induces JNK-mediated apoptosis, resulting in a dramatic loss
of eye tissue. We used this “small eye phenotype” as the basis for an assay for dominant
suppressors of this activity. In order to isolate rate-limiting components involved in Eiger-
induced apoptosis a dominant mutagenesis screen was performed. Over 100 mutations that
dominantly weaken the Eiger-JNK pathway were isolated. As expected, some of these
mutations affected already known components of the Eiger pathway. Importantly we also
isolated mutations in the genes dTAB2, Mkk4 and lilliputian, encoding for proteins that had
not yet been implicated in the Eiger pathway of Drosophila.
dTAB2 was shown to act as an adaptor molecule linking the receptor complex component
dTRAF1 to one of the key signaling components dTAK1, demonstrating a conserved role for
TAB proteins from flies to humans. Our experiments further suggest that in Drosophila both
JNK activating kinases, Hemipterous (dMkk7) and Mkk4, are required for TNF-induced JNK
activation, which is in contrast to the situation in mammals. Whether a human Lilliputian-like
transcription factor also contributes to TNF-induced, AP-1-mediated transcription, as our
results in Drosophila indicated, remains to be elucidated.
The mapping of the other suppressor mutations and the characterization of their
corresponding gene products may uncover further important aspects of this evolutionarily
ancient signaling pathway and possibly reveal new drug targets for the treatment of diseases
like cancer, autoimmune disorders and diabetes.
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3  Introduction
The existence of a cytokine with a tumor necrotizing potential, that is induced by LPS and
mediates regression of tumors, was already described more than three decades ago
(Carswell et al., 1975; Williams and Granger, 1968). However, only in 1984/1985 the first two
members of the tumor necrosis factor (TNF) superfamily, TNF- and TNF-, have been
purified and cloned (Aggarwal et al., 1985a; Aggarwal et al., 1985b; Aggarwal et al., 1984;
Gray et al., 1984; Pennica et al., 1984). They represent the two founding members of the TNF
superfamily, currently consisting of 19 ligands. Several years later the first receptors
belonging to the tumor necrosis factor receptor (TNFR) superfamily, now consisting of 29
members, were identified. TNF ligands are type II transmembrane proteins (intracellular N-
terminus and extracellular C-terminus) containing a characteristic “TNF homology domain”
(THD) in the C-terminal part of the protein. The THD is required for receptor binding and
trimerization of the ligand. In some cases cleavage of membrane-bound ligands by
metalloproteases is required in order to generate active soluble ligands. TNFRs are type I or
type III (lack of a signal peptide) transmembrane proteins, which have an intracellular C- and
an extracellular N-terminus. These receptors carry between one and six characteristic
“cysteine-rich domains” (CRD) in their extracellular part. CRDs are involved in ligand binding.
The TNFR superfamily is subdivided into two subgroups: The so-called death-receptors, that
carry an intracellular death-domain (DD) and a second group lacking the DD. Death-receptors
bind Jun-N-terminal kinase (JNK)-inducing TRAF proteins through the DD-containing adaptor
molecule TRADD, which binds via homophilic interaction to the receptor. The Caspase-8-
recruiting, DD-containing adaptor molecule FADD can either directly (e.g. FAS) or indirectly
via TRADD (e.g. TNFR-1) bind to a death-receptor. Some of the TNFRs lacking a DD bind
directly to TRAFs (e.g. TNFR-2), but all of them fail to bind to TRADD or FADD and therefore
fail to induce Caspase-8-dependent apoptosis. Both, ligands and receptors, have to form a
homotrimer to become active signaling components (Aggarwal, 2003; Wajant et al., 2003).
Introduction 4
3.1  Biological Functions of TNF
TNF ligands play prominent roles in the regulation of physiological processes, such as the
immune system, inflammation, haematopoiesis and the development of hair follicles, sweat
glands and neuronal networks (Locksley et al., 2001). However, deregulation of TNF
signaling is associated with pathological conditions, including autoimmune disorders, cancer
and diabetes (Aggarwal, 2003; Chen and Goeddel, 2002). A bigger picture of biological
functions of TNF is depicted in Figure 1. For some of these diseases TNF ligands and
receptors are being evaluated as drug targets for therapy. TNF- inhibitors (Etanercept or
Infliximab) for example have been proven to be very effective in treatment of rheumatoid
arthritis (Luong et al., 2000), but for therapy of multiple sclerosis it turned out to have
deleterious effects (Kassiotis and Kollias, 2001). The cellular outputs of the TNF signal are as
widespread as the conditions mentioned above. Activation of TNFRs induces several
intracellular signaling pathways that can lead to apoptosis, survival, proliferation and
differentiation. The high number of members belonging to the TNF- and TNFR-superfmailies
and the pleiotropic functions of TNF clearly highlight the complexity of TNF biology in
mammals. This complexity is further enhanced by the crosstalk occurring between the
different intracellular signaling pathways that are induced by TNFRs.
     Figure 1  Physiological (green) and pathological (blue) processes influenced by TNF
     signaling are indicated (Aggarwal, 2003).
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3.2  Signaling Pathways Induced by TNF
Primarily three intracellular pathways are activated upon binding of TNF ligands to their
receptors. An overview of the components involved in the activation of these pathways given
in this section is by far not complete, but reflects the present view of the “canonical” TNF
pathway (Figure 2). Not all TNFRs induce all three pathways, but only one or two of them. In
addition there are also other “non-canonical” pathways reported (p38, PKB-Akt, Ras-Raf) that
are induced by a subset of TNF ligands. Activation of the transcription factors NFB and AP-1
as well as induction of the initiator caspase-8 are the three canonical pathways briefly
described in the following paragraph (Wajant et al., 2003).
(1) NFB activation: Recruitment of RIP into the receptor complex is a crucial step in the
induction of NFB. RIP is involved in the activation of IKK, an inhibitor of IB. In non-
stimulated cells IB masks the nuclear localization signal (NLS) present in NFB.
Phosphorylation of IB by IKK marks it for proteasomal degradation, thereby allowing NFB
to enter the nucleus and activate transcription of target genes. Actvation of NFB plays a role
in the immune responses and is a survival signal for the cell. This TNF-induced survival signal
is the reason why a lot of cell-types actually do not undergo apoptosis upon TNF stimulation
(Wajant et al., 2003).
(2) AP-1 activation: TRAF2 is required to promote the induction of the JNK pathway upon
TNF stimulation. How exactly TRAF2 mediates TNF-induced activation of JNK is not very well
understood. Germinal center kinases (GCK) have been shown to bind to TRAF2 and to be
able to activate different JNKKKs. Activation of the JNK signaling cascade finally leads to the
phosphorylation of the transcription factor AP-1 consisting of c-Jun and c-Fos. While TNF-
induced JNK signaling is generally believed to be important in the regulation of immune
responses (Wallach et al., 1999), its role in apoptosis is controversial. JNK signaling is
reported to have pro- as well as anti-apoptotic effects (Deng et al., 2003; Liu et al., 1996;
Natoli et al., 1997).
(3) Caspase-8 activation: Recruitment of the initiator caspase-8 by FADD is the initial step for
activation of the effector caspase-3. This way of induction of programmed cell death,
apoptosis, is also known as the extrinsic apoptotic pathway. Another mechansim is the
intrinsic apoptotic pathway, which is activated by intrinsic signals, such as DNA damage. The
apoptosome, consisting of caspase-9 and Apaf-1, is the key player of the intrinsic apoptotic
pathway. Mitochondria play an important regulatory role in the intrinsic pathway (Hengartner,
2000).
Introduction 6
A pathway mechanistically very similar to the TNF pathway is the TLR (Toll-like receptor)
pathway. It also plays a prominent role in the immune system. In the TLR pathway TAK1 is
the major inducer of NFB as well as JNK (Kawai and Akira, 2006). The importance of NIK
(NFB-inducing kinase) in NFB activation is still not fully understood. In general, the main
difference between the TLR and TNF pathway is that, due to the lack of a DD, TLRs fail to
directly recruit FADD to induce caspase-8-dependent apoptosis (Figure 2). However,
exceptions are known bringing the TNF and TLR receptors mechanistically even closer
together indicating that they share very similar signaling modules that possibly have been
adopted independently during evolution. TLR-2 for example has been shown to induce
caspase-8-dependent apoptosis by homophilic DD-mediated binding of FADD to MyD88
(Aliprantis et al., 2000).
Figure 2  TNF- and TLR-signaling in mammals and Drosophila.
3.3  TNF/Eiger Signaling in Drosophila
In the genome of Drosophila melanogaster a single gene is predicted that encodes a protein
with homology to mammalian TNFs. Eiger, the 415aa product of this gene, contains a N-
terminal transmembrane domain and a C-terminal THD, both characteristic for TNF ligands.
Overexpression of eiger (egr) in the Drosophila compound eye leads to a dramatic ablation of
eye tissue (Figure 3) (Moreno et al., 2002b). Interestingly, in flies homozygous mutant for
Dredd (Drosophila caspase-8) or dFADD (not shown) Eiger is still able to induce a small eye
phenotype (Moreno et al., 2002b), indicating that in Drosophila the FADD-caspase-8 module
is not required for Eiger-induced loss of eye tissue. But it is important to note, that Dredd and
dFADD are involved in a Drosophila Toll-like pathway, called IMD (Leulier et al., 2000; Naitza
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et al., 2002). The IMD pathway leads to the activation of Rel, one of the Drosophila homologs
of NFB, and mediates innate immunity against gram-negative bacterial infection (Hultmark,
2003). This is an exciting observation suggesting that early in evolution the FADD-caspase-8
branch was used by TLRs and only later was adopted by the TNF system. The role of
mammalian FADD and caspase-8 in NFB activation has not been properly elucidated. The
situation again seems to be more complex than in Drosophila, indicated by some reports
claiming FADD-caspase-8 to be an inducer of NFB activation (Chaudhary et al., 2000; Hu et
al., 2000; Rathore et al., 2004) while others suggest an inhibitory role for FADD-caspase-8 in
NFB activation (Bannerman et al., 2002; Duckett, 2002).
puckered (puc), a target gene of the JNK pathway in Drosophila, encodes a dual-specificity
phosphatase that acts as a feed-back inhibitor of the pathway by directly inhibiting Basket
(Bsk, Drosophila JNK) activity (Martin-Blanco et al., 1998). Co-expression of Puc together
with Eiger completely suppressed the small eye phenotype strongly suggesting that Eiger
only acts through Bsk. Removing one or two copies of components of the Drosophila JNK
pathway (msn (Igaki et al., 2002; Moreno et al., 2002b), dTAK1 (Geuking et al., 2005), hep
(Igaki et al., 2002), bsk (Igaki et al., 2002; Moreno et al., 2002b), and djun (Appendix)) also
suppressed the small eye phenotype confirming its role in Eiger-induced eye tissue ablation.
In addition a deficiency that deletes dTRAF1 (encoding the homolog of TRAF2) also
dominantly suppressed the small eye phenotype (Moreno et al., 2002b).
The main transducer of apoptosis in flies is the Drosophila counterpart of the mammalian
apoptosome consisting of Dark (Drosophila Apaf-1) and Dronc (Drosophila caspase-9). In
non-dying cells Drosophila caspases are bound by “inhibitor of apoptosis proteins” such as
DIAP1. So far there are at least five pro-apoptotic genes known in Drosophila, of which all
induce apoptosis by releasing Dronc from its inhibition by DIAP1 (Meier et al., 2000). These
genes are head involution defective (hid) (Grether et al., 1995), reaper (rpr) (White et al.,
1996), grim (Chen et al., 1996), sickle (Christich et al., 2002; Srinivasula et al., 2002; Wing et
al., 2002) and jafrac2 (Tenev et al., 2002). All of them except jafrac2 are encoded at the same
locus in the Drosophila genome (75C). The discovery of a deficiency (Df(3L)H99) deleting
three of them, hid, rpr and grim, was the starting point for the research field of developmental
apoptosis in Drosophila (White et al., 1994). In flies possibly all apoptosis-inducing events,
such as DNA damage or developmental apoptosis, lead to the transcriptional upregulation of
one or more of these pro-apoptotic genes (Meier et al., 2000).
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Several experiments clearly indicated that overexpression of Eiger in the Drosophila eye
indeed induces Dronc-dependent apoptosis. Co-expression of DIAP1 or a dominant negative
form of Dronc (CARD) suppresses the small eye phenotype. In addition, flies heterozygous
for dark or Df(3L)H99 also display a suppressed small eye phenotype. The involvement of
pro-apoptotic genes was further confirmed by detection of transcriptional upregulation of hid
upon Eiger-induced JNK signaling (Moreno et al., 2002b).
In summary, Eiger activates the JNK pathway, which in turn leads to transcriptional
upregulation of at least one of the pro-apoptotic genes (hid). Subsequently Hid releases
Dronc from its inhibition by DIAP1 leading to the initiation of programmed cell death (Figure
3).
Eiger
Basket 
(JNK)
Misshapen 
(MAP4K)
dTAK1 
(MAP3K)
Wengen ?
Hemipterous 
(JNKK)
hid
DIAP1 Apoptosome 
DARK + DRONC
Apoptosis
HID
dJun
dTRAF1
GMR-egr GMR-egr/bsk1wt
    Figure 3  Eiger overexpression in the Drosophila compound eye leads to JNK-mediated
    transcriptional upregulation of hid and subsequent induction of apoptosis.
In mammals one way for NFB to exert its anti-apoptotic/survival function is by inducing the
transcription of genes whose products were shown to directly inhibit the JNK pathway (De
Smaele et al., 2001; Tang et al., 2001b), assigning a pro-apoptotic rather than an anti-
apoptotic role to the JNK pathway. When NFB is blocked TNF’s potential to induce
apoptosis increases dramatically (Wajant et al., 2003). One such a NFB target gene is
gadd45. Gadd45 directly inhibits JNK signaling by targeting Mkk7 (Papa et al., 2004a;
Papa et al., 2004b). However, when the closest structural Drosophila homolog (CG11086)
was co-expressed with Eiger, no inhibiting effect was observed (not shown). Whether the
Drosophila homologs of NFB (Relish, Dorsal, Dif) have an inhibitory effect on Eiger signaling
remains to be elucidated. Relish indeed was reported to have an inhibitory effect on dTAK1 in
LPS-induced JNK activation (Park et al., 2004). The anti-apoptotic role of NFB is thought to
depend on its simultaneous activation together with induction of apoptosis by TNF. Since no
activation of NFB by Eiger was observed so far (Igaki et al., 2002), a physiological crosstalk
between NFB and JNK in Eiger signaling is rather unlikely.
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Since the Drosophila genome encodes only a single homolog of TNF, it was obvious to look
for a homolog of a TNFR as well. Indeed, such a search was successful and lead to the
identification of a single Drosophila TNFR homolog called Wengen (Wgn) (Kanda et al., 2002;
Kauppila et al., 2003; Röthlisberger, 2002). Wengen is a 343aa type III transmembrane
protein with a characteristic N-terminal CRD. However, unlike mammalian TNFRs, Wengen
contains neither a DD nor a consensus TRAF binding motif. Co-expression of a UAS-RNAi-
hairpin construct of wgn as well as heterozygousity for a deficiency uncovering the wgn locus
(Df(1)E128) was reported to suppress the Eiger-induced small eye phenotype (Kanda et al.,
2002). Also RNAi experiments in cell culture indicated a ligand-receptor relation for Eiger and
Wengen (Kauppila et al., 2003). While Kanda et al. (2002) claimed to observe a physical
interaction between Eiger and Wengen, Kauppila et al. (2003) were not able to reveal such an
interaction. However, the in vivo experiments performed by Kanda et al. (2002) could not be
reproduced. Both, co-expression of a UAS-wgn-hairpin transgene as well as heterozygousity
for Df(1)E128, did not suppress the small eye phenotype in our hands (not shown). More
importantly, a targeted knock-out allele of wgn did, even in a homozygous state, not suppress
the Eiger-induced small eye phenotype (Röthlisberger, 2002). Aside from the conclusion that
Wengen is not the receptor of Eiger, it is possible that there is redundancy at the level of the
receptor. Whether an unknown type of receptor is also involved in the primordial TNF
signaling cascade would be an interesting finding that remains to be investigated.
So far new components in the TNF signaling network were mainly identified by biochemistry
or on the basis of homology searches. The existence of a single Drosophila TNF homolog
offers the possibility to apply also genetic approaches to study its signaling mechanisms. In
this thesis a genetic screen with the goal to identify novel components in the Eiger pathway is
described. The identification and characterization of new components, such as novel
receptors, may shed light on, as yet, unknown mechanisms of TNF signal transduction as
well as on new therapeutic opportunities for the treatment of diseases where TNF signaling is
deregulated.
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4  Results
4.1  The EMS Screen
Based on the fact that removing one copy of known components of the Drosophila JNK
pathway is sufficient to suppress the Eiger-induced small eye phenotype (Figure 3) (Igaki et
al., 2002; Moreno et al., 2002b), we designed a screen for dominant suppressors of this
phenotype (Geuking et al., 2005). By crossing mutagenized chromosomes into the “small
eye” genetic background (GMR-Gal4 UAS-egr, in this thesis called GMR-egr), the progeny of
such a cross can easily be screened for dominant suppressors. In a pilot screen, where yw
males were mutagenized and mated with virgins of the following genotype, yw; GMR-egr /
CyO ; y+ / y+ , approximately 5’000 chromosomes were screened and 21 suppressors were
identified. Importantly the pilot screen confirmed that dominant suppressors can be identified
with this setup.
However, using virgins of the GMR-egr stock for these crosses also leads to various technical
problems. Since the GMR-egr stock is very weak in viability, it is hard to get enough virgins to
run the screen efficiently. Flies homozygous for the GMR-egr chromosome are lethal and also
heterozygous animals display reduced viability (i.e. not all of them hatch). This already
reduces the efficiency of the screen dramatically. Furthermore only 50% of the screened F1
progeny carries the right genotype, the other 50% will carry the CyO balancer. It is therefore
very time consuming to first sort out the flies with the correct genotype. The y+ insertion on
the third chromosome is used as a marker in the process of mapping the isolated suppressor
mutations to a chromosome (Geuking et al., 2005). To improve the efficiency of the screen
we subsequently mutagenized males carrying the GMR-Gal4 insertion on the second
chromosome (yw; GMR-Gal4; +). These males were then mated with virgins carrying a UAS-
egr and a y+ insertion on the second and third chromosome, respectively (yw; UAS-egr; y+).
Both stocks display a high fitness/viability and with this setup 100% of the F1 progeny has the
right genotype to be screened. It is important to mention that with this setup some of the
suppressors that will be isolated will carry mutations in the GMR-Gal4 transgene. But those
can easily be identified based on two criteria (Geuking et al., 2005):
1) The suppressor mutation cannot be separated from the GMR-Gal4 insertion
by recombination.
2) The unrelated big eye phenotype induced by expression of UAS-Inr under
control of GMR-Gal4 (Brogiolo et al., 2001) is also reverted if the GMR-Gal4
transgene is mutated.
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Using the above described setup approximately 55’000 flies were screened and 117
suppressors were isolated in total (1 on X, 87 on II, 29 on III). This corresponds to 0.21% of
the total number of screened flies and represents the normal yield of an EMS screen. That
only one mutation on chromosome X was obtained is due to the genetics of the screen, which
only allows one to isolate viable mutations on chromosome X, which eventually can even be
lost again (Geuking et al., 2005).
In order to characterize the identified suppressor mutations, complementation analysis with
known components of the pathway was conducted, namely, using misshapen (msn), basket
(bsk), djun (jra) and dfos (kayak). All suppressor mutations that mapped to the second
chromosome were tested for complementation with bsk and djun, which are also located on
the second chromosome. Equally, all hits on the third chromosome were tested using msn
and dfos alleles. Although mutations in djun and dfos do not dominantly suppress the Eiger-
induced small eye phenotype (not shown), they were included in this analysis because of the
possibility that strong or dominant negative alleles of djun or dfos could have been isolated in
the screen. djun and dfos were shown to be involved in the Eiger pathway by other genetic
experiments and RNAi in a cell-culture-based reporter assay (see Appendix and Chapter 4.7).
The only lethal complementation group we identified in this complementation analysis is a
group of ten suppressor mutations that failed to complement the lethality of a bsk loss of
function allele (bsk1). Sequencing the bsk coding region of these mutants revealed molecular
lesions in all of them (Geuking et al., 2005) confirming that our screening setup indeed works.
At the same time this result revealed that we did not isolate mutations in djun, dfos or,
surprisingly, msn. One explanation for not having obtained mutations in msn could be that the
suppression brought about by dominant loss of msn is below the phenotypic threshold we
screened for. Indeed, the suppression of the small eye phenotype observed by dominant loss
of msn is rather weak (Igaki et al., 2002; Moreno et al., 2002b). Another explanation is that,
e.g. depending on the chromatin structure, EMS may have different access to different
chromosomal regions. hep and dTAK1, two further known components of the Eiger pathway,
were excluded from this analysis because they are located on the X chromosome. hep null
mutants are homozygous lethal, whereas dTAK1 mutants are homozygous viable. In any
case it is not possible to perform a lethality-based complementation analysis for genes on the
X chromosome. Only one suppressor mutation located on chromosome X was isolated in the
screen (G14). This suppressor behaved exactly as dTAK1 mutants: it was homozygous viable
and recessively completely suppressed the small eye phenotype. Genetic rescue
experiments and sequencing of the dTAK1 coding region in this suppressor confirmed it to be
a novel dTAK1 allele (Geuking et al., 2005).
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Epistasis experiments with GMR-hid (GMR-Gal4 EP-hid) indicated that all suppressor
mutations act genetically upstream of hid transcription: none of the mutations suppressed the
small eye phenotype induced by hid expression in the eye (not shown). This phenotype was
strongly suppressed by co-expression of a dominant negative version of Dronc (UAS-CARD)
(Figure 4) proving that this phenotype is indeed dependent on the apoptotic machinery. A
mutant of the initiator caspase dronc (dronc51) (Chew et al., 2004), which acts downstream of
hid in the pathway, does not dominantly suppress either GMR-egr or GMR-hid (not shown).
Therefore it was not surprising that all suppressor mutations from the screen complemented
the lethality of dronc51, as it is consistent with the conclusion that all these mutations act
genetically upstream of hid transcription. For epistasis experiments with a constitutive active
form of Hep see the specific result sections for the genes identified in the screen (Chapter
4.5, 4.6, 4.7) and Appendix.
Figure 4  The small eye phenotype induced by expression of EP-hid under the control of GMR-Gal4 is strongly
suppressed by co-expression of a dominant negative form of Dronc (UAS-CARD).
4.2  The Deficiency Screen
In parallel to the EMS screen we screened the whole deficiency collection from Exelixis
(Parks et al., 2004) and a subset of deficiencies created by the DrosDel project (Ryder et al.,
2004) for dominant suppressors of the small eye phenotype. The Exelixis collection alone
uncovers approximately 56% of the Drosophila genome. These deficiencies are in an
isogenic background and their breakpoints are molecularly mapped, which is a major
advantage compared to other deficiency collections available. The purpose of screening
these deficiencies was to identify chromosomal regions important for Eiger signaling that
possibly are weakly accessible by EMS. In addition the isolation of deficiencies that
dominantly suppress the small eye phenotype will be very useful in order to map the EMS-
induced suppressor mutations.
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The testing of approximately 450 Exelixis and 140 DrosDel deficiencies revealed a total of six
deficiencies with a medium to strong potential to suppress the small eye phenotype (Table 1
and Appendix). Two of the deficiencies, Df(3L)ED224 and Df(3L)ED225, are overlapping and
uncover the genomic region 75C of the well known pro-apoptotic genes head involution
defective (hid), reaper (rpr), grim and sickle (skl) confirming their role in Eiger-induced
apoptosis. Df(3L)ED224 and Df(3L)ED225 overlap in only six genes including grim and rpr
but not hid and skl (Fugure 75C). Df(3L)ED225, which does not delete hid, indicates that
Eiger-induced apoptosis is not only mediated by hid, but also by at least one of the three
other pro-apoptotic genes. Another deficiency, Df(3R)Exel6149, is included in Df(3R)ED5296
and in this case narrows the region of interest down to 27 genes. Df(2R)Exel6069 and
Df(3L)Exel6107 delete only 20 and 25 genes, respectively. The suppression observed with
Df(2R)Exel6069 was confirmed with Df(2R)BSC26 that uncovers the same region but in
addition extends proximally and distally (Table 1). Df(3L)Exel6107 failed to be confirmed with
corresponding deficiencies (Df(3L)ZN47 and Df(3L)CH20, discussed in Chapter 4.10). None
of the deficiencies suppressed the small eye phenotypes observed with GMR-hid or GMR-
hep
CA indicating that the responsible genes act in parallel or upstream of Hep (not shown).
Testing all available loss of function alleles of the genes deleted in any of the three small
Exelixis deficiencies for suppression of the small eye phenotype did not reveal the identity of
the responsible genes. Furthermore, all mutations we obtained from the EMS screen also
complemented the lethality of each of these three deficiencies. Therefore, either none of the
EMS mutations affects genes disrupted in any of these three deficiencies or loss of function
mutations of the affected genes are homozygous viable.
Deficiency Confirmed with Comments
Df(3L)ED224/Df(3L)ED225 each other deletes locus 75C
Df(2R)Exel6069 Df(2R)BSC26 20 genes deleted
Df(3R)Exel6149/Df(3R)ED5296 each other 27 genes deleted
Df(3L)Exel6107 failed to be confirmed! 25 genes deleted
Table 1  Deficiencies isolated in the deficiency screen.
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4.3  Genetic Rough Mapping
Since neither complementation analysis with identified deficiencies nor a partial
complementation analysis within the pool of EMS mutations itself revealed any further lethal
complementation group, we decided to first roughly map all the mutations relative to a genetic
marker in order to subdivide them into different groups. Suppressors belonging to the same
group can then be tested in a complementation analysis again. ~90% of the chromosomes
isolated from our EMS screen are homozygous lethal. This is not necessarily due to the
suppressor mutation itself, but possibly due to second lethal hits on the chromosome.
To map second chromosomal suppressor mutations we simply used the GMR-Gal4 insertion
as a genetic marker. By inverse PCR the GMR-Gal4 driver was determined to be inserted at
57F6. Chromosomes carrying the GMR-Gal4 insertion and a suppressor mutation were
allowed to recombine with a wildtype chromosome in females. Such virgins were crossed to
UAS-egr males. The number of GMR-Gal4 progeny (marked by a “dark red” w+ versus the
weak “orange” w+ of the UAS-egr insertion) with a suppressed eye phenotype in relation to
the number of GMR-Gal4 progeny with a small eye phenotype reflects the relative genetic
distance between the suppressor mutation and the GMR-Gal4 insertion. The closer a
mutation is to the GMR-Gal4 insertion the less likely it is that they will be separated by
recombination (Figure 5a).
A similar analysis was performed for the few mutations that were obtained from the pilot
screen, where wildtype chromosomes were mutagenized, The “wildtype” chromosome
carrying a suppressor mutation was allowed to recombine with the GMR-Gal4 chromosome.
When again crossing such virgins back to UAS-egr males the progeny was analyzed in a
reciprocal way than described above (Figure 5b).
It is important to notice that the distance values that are obtained with this method are only
relative and not absolute values. It even turned out that only values obtained by the same
crossing scheme can be compared with each other. This is probably due to the fact that the
fitness of a GMR-Gal4 chromosome that does not carry a suppressor mutation is much
weaker when crossed back to a UAS-egr stock.
This analysis revealed three major groups of suppressor mutations on the second
chromosome defined by their relative genetic distance (in % rgd, see Figure 5) to the GMR-
Gal4 insertion. (1) 0 rgd, (2) 2-8 rgd, (3): 28-36 rgd. Another class is represented by the new
bsk alleles discussed earlier. These were subjected to this analysis as a control and mapped
25-33 rgd away from the GMR-Gal4 insertion. Since the insertion is located on 2R and bsk on
2L, values higher than 25 rgd may already reflect uncoupled inheritance. As mentioned
before, the values for the mutations obtained in the pilot screen differ from these, but they
could also be used to determine whether a mutation is in close proximity to the locus where
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the GMR-Gal4 transgene is inserted or located on the opposite chromosome arm 2L. Values
of 12-23 rgd and 69-124 rgd obtained by crossing scheme 5b belong to group 2 and 3,
respectively (see below). The exact value obtained for each suppressor mutation is listed in
the Appendix.
Group 1 reflects mutations in the GMR-Gal4 transgene. All but five of them also reverted the
unrelated Inr big eye phenotype and therefore fulfill the two criteria mentioned earlier (see
Appendix). That the other five mutations affect a gene that just lies very close to the GMR-
Gal4 insertion is rather unlikely, because, in these special cases, a very high number of
progeny was screened for a recombination event. One possible explanation for not
suppressing the Inr-induced big eye phenotype is, that these mutations just weaken the Gal4
expression to an extent that the UAS-Inr transgene is still sufficiently activated, but not the
UAS-egr transgene.
Group 2 seemed to be located in proximity of the GMR-Gal4 insertion. In theory, by
comparing the chromosomal locations, these mutations could affect a gene deleted in
Df(2R)Exel6069. Indeed, using overlapping deficiencies and sequencing candidate genes we
identified mutations in dTAB2 in 39 of these 42 stocks. For a detailed description see Chapter
4.5.
Group 3 reflects mutations located on 2L, which complement the lethality of bsk alleles.
Complementation analysis with the five suppressor mutations of this class revealed that four
of them fail to complement each other, and therefore represent a further lethal
complementation group called L1. For detailed characterization of L1 see Chapter 4.6.
To map the third chromosomal mutations in a similar approach, three RFP (red fluorescent
protein)-marked insertions (J. Bischof, unpublished) were used as genetic markers. Two of
them (RFP15@85E, RFP4@62B) were chosen due to proximity to Df(3R)Exel6149 and
Df(3L)Exel6107 located at cytological position 85A2-5 and 64E5-F6, respectively. These
deficiencies were identified as suppressors in the deficiency screen described earlier. The
third one, RFP5, is inserted at position 92A (Figure 10). Again, mutated chromosomes were
allowed to recombine with the RFP-marked chromosome in females. These virgins were
crossed back to GMR-egr/CyO males. The number of non-CyO RFP progeny (sorted under
the fluorescence binocular) with a suppressed eye phenotype in relation to the number of
non-CyO RFP progeny with a small eye reflects the relative genetic distance to the RFP
insertion (Figure 5c).
This analysis revealed that 23 of the 29 third chromosomal suppressor mutations are located
very close to Df(3R)Exel6149 (see chapter 4.7). The relative genetic distances to the RFP
insertions obtained for all third chromosomal mutations are listed in the Appendix.
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Figure 5  Crossing schemes for genetic rough mapping relative to a genetic marker.
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4.4  Genetics of FLP Mapping
Second chromosomal EMS-induced suppressors that could not be mapped with the help of
deficiencies identified in the deficiency screen were subjected to high resolution FLP
(fragment length polymorphism) mapping. With this technique FLPs present between the
mutated chromosome (GMR-Gal4 or wildtype) and a reference chromosome (EP2L or
FRT40) are used as genetic markers. For a detailed description of this method see Zipperlen
et al. (2005).
In order to obtain suitable recombinants that can be analyzed with this technique the following
genetic procedure was applied. The mutant chromosome was allowed to recombine with the
reference chromosome in females. These virgins are crossed back either to UAS-egr or
GMR-egr males, depending on whether the GMR-Gal4 or the wildtype chromosome was
mutagenized (Figure 6). The FLPs of single flies of the progeny displaying either a small eye
or a suppressed phenotype were analyzed for hetero- or homozygousity. Due to the lack of a
suitable additional marker, it was not possible to identify recombination events already before
the analysis. But it turned out that a large number of the analyzed single flies indeed carried a
recombination event. Although the UAS-egr, GMR-Gal4 and the wildtype second
chromosome were not completely isogenic, enough useful FLPs could be identified that are
identical in these three stocks but distinguishable from the corresponding FLP on the
reference chromosome (EP2L or FRT40). By analyzing flies that still carry the suppressor
mutation and flies that lost it (small eyes) the mutation could be approached from the distal
and proximal side.
For those suppressors where FLP mapping was applied, the determined FLP interval is given
in the Appendix. For the exact chromosomal position of the corresponding FLPs check Berger
et al. (2001) and Zipperlen et al. (2005). This approach was successfully applied for the
identification of the gene that is affected in complementation group L1 (see Chapter 4.7).
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Figure 6  Crossing schemes for generation of recombinants used for FLP mapping.
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4.5  Identification and Characterization of Drosophila TAB2
Geuking, P., Narasimamurthy R. and Basler K.
A Genetic Screen Targeting the Tumor Necrosis Factor/Eiger Signaling Pathway:
Identification of Drosophila TAB2 as a Functionally Conserved Component
Genetics 171: 1683-1694, 2005
In this paper we describe the isolation and characterization of mutations in bsk, dTAK1 and
Drosophila TAB2. In particular we focus on the description of the screen and the
characterization of dTAB2.
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4.6  Identification and Characterization of Drosophila Mkk4
Manuscript in the format of a “Genetics Note” in preparation.
A Non-redundant Role for Drosophila Mkk4 and Hemipterous in Eiger Signaling
Peter Geuking, Rajesh Narasimamurthy and Konrad Basler
Institut für Molekularbiologie, Universität Zürich, CH-8057 Zürich, Switzerland
ABSTRACT
Mutations in Drosophila Mkk4 strongly suppress Eiger-induced, Jun-N-terminal kinase (JNK)-
mediated apoptosis, revealing a non-redundant function for dMkk4 and Hemipterous (dMkk7)
in this signaling cascade. These findings are supported by the physical interaction of dMkk4
with the up- and downstream kinases dTAK1 and Basket (dJNK).
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The JNK pathway, one of the three major classes of mitogen-activated protein (MAP) kinase
pathways (Erk, p38 and JNK), is induced by pro-inflammatory cytokines, such as Tumor
Necrosis Factor (TNF) and Interleukin-1 (IL-1), and several forms of environmental stress
(e.g. osmotic stress, irradiation, and oxidative stress) (Davis, 2000; Ip and Davis, 1998;
Weston and Davis, 2002). In mammals JNK is reported to be activated by the two MAPK
kinases (MAPKK) Mkk4 and Mkk7, with Mkk7 mainly involved in TNF- or IL-1-induced JNK
activation and both, Mkk4 and Mkk7, required for stress induced activation of JNK (Cuenda,
2000; Holland et al., 1997; Lawler et al., 1997; Moriguchi et al., 1997; Tournier et al., 2001;
Tournier et al., 1997). So far only mutations in the Drosophila homolog of Mkk7, hemipterous
(hep), have been isolated, but not in Drosophila Mkk4. Null mutations in hep lead to a defect
in dorsal closure, a well characterized process in the Drosophila embryo that depends on JNK
signaling (Glise et al., 1995). This already clearly demonstrates that in this situation Mkk4
cannot substitute for Hep function. Although it has been reported that in mammals Mkk4 and
Mkk7 may synergistically activate JNK (Fleming et al., 2000; Lawler et al., 1998), this does
not seem to be the case for Hep-mediated Bsk activation in the process of dorsal closure. As
already mentioned in mice the situation seems to be more complicated. Both, Mkk4 and Mkk7
single mutants are embryonic lethal, but display different phenotypes (Ganiatsas et al., 1998;
Nishina et al., 1999; Tournier et al., 2001; Yang et al., 1997), indicating partially overlapping
sets of functions.
In a dominant suppressor screen for new components of the Eiger-JNK-pathway in
Drosophila (Geuking et al., 2005) we identified several mutations in Drosophila Mkk4. Some
of the EMS-induced mutations suppressing Eiger-induced cell death we obtained in this
screen, mapped genetically very close to a deficiency that also suppresses the Eiger-induced
small eye phenotype (Df(3L)Exel6149). Df(3L)Exel6149 was identified by screening the whole
Exelixis deficiency kit (Parks et al., 2004). Since Mkk4 is deleted in Df(3L)Exel614, we
sequenced the coding region of Mkk4 in those EMS alleles. Indeed molecular lesions were
detected in 21 of them (Table 1, Figure 1A). All mutations identified are viable over
Df(3L)Exel6149 or in heteroallelic combinations (but in some cases homozygous lethal due to
second hits on the chromosome), confirming that Mkk4 does not crucially participate in dorsal
closure of the Drosophila embryo.
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Allele DNA Level Protein Level
G48 GCAGTA Ala10Lys
G356 653bp ins. at Ser38 AA11 of ins. is a STOP
G673 CAGTAG
TTCTAC
Gln66STOP
Phe184Tyr
G344 CGATGA Arg154STOP
G993 GATAAT Asp168Asn
G451 GTGATG Val171Met
G201 GATAAT Asp249Asn
G343 GTGATG Val250Met
G894 GTGGAG Val250Asn
G136 CCGTCG Pro252Ser
G863 GGTGAT Gly269Asp
G414 CAGTAG Gln273STOP
G39 CCGCTG Pro292Leu
G583 CCGTCG Pro292Ser
G657 GATAAT Asp308Asn
G504 GAGAAG Glu318Lys
G270 CCCCTC Pro325Leu
G587 TGGTAG Trp329STOP
G1010 5’ splice site intron 3:
AG/GTAG/AT
-
G680 CAATAA Gln341STOP
G262 GTGATG Val361Met
Table 1  Molecular lesions identified in Mkk4. Alleles are ordered according their position in the protein.
Removing one copy of Mkk4 leads to a potent suppression of the Eiger-induced small eye
(Figure 1B, C, and D). Removing two copies of Mkk4 does not significantly enhance this
suppression (Figure 1E). It is important to note that already in hemizygous mutant hep males
(hypomorphic hep1 allele) a very good suppression of the Eiger-induced small eye phenotype
is observed (Igaki et al., 2002) (Figure 1F), indicating that in Drosophila both MAPKKs, Mkk4
and Mkk7 (Hep), are required for proper transduction of the Eiger signal from dTAK1 to Bsk.
This demonstrates that in Drosophila, in contrast to mammals, Mkk4 is required for TNF
(Eiger)-mediated JNK activation. The effect in hep1–Mkk4 double mutant males remains to be
analyzed. Introducing a tubulin-Mkk4 rescue transgene reverts the observed dominant
suppression indicating that indeed Mkk4 is responsible for this effect (Figure 1G). However,
this rescue transgene seems not to be specific, because it also reverted the suppression
brought about by dominant loss of bsk (complete) and dTAB2 (only partially). The same could
be observed with a tub-dTAB2 rescue transgene, that also reverted the suppression observed
by dominant loss of bsk but not the one brought about by the uncharacterized allele G56 for
example (not shown). This effect can be explained by the fact that the tub-promotor
expresses the respective gene slightly higher than at endogenous levels, thereby slightly
over-activating the pathway but not yet fully enabling the dominant negative effect observed
with UAS-constructs. In our case, this results in the observed non-specificity of these rescue
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transgenes mainly because GMR-egr is a very sensitive background and because dominant,
and not recessive, effects are reverted. The slight over-activation induced by use of the tub-
constructs was observed to only completely revert the dominant suppression induced by loss
of a downstream suppressor, offering the possibility to use this effect as an epistasis tool. A
genomic rescue construct would most likely be specific, as it is the case for the genomic
dTAK1 rescue construct, which specifically reverts the suppression caused by loss of dTAK1
(not shown).
Mkk4G680/+ Mkk4G680/Df6149 hep1
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Figure 1  (A) Schematic representation of dMkk4. Alleles (black) and Ser/Thr phosphorylation sites (green) are
indicated. (B)-(I) are in a GMR-egr (GMR-Gal4 UAS-egr) background. (B) GMR-Gal4/+ control eye. (C) GMR-egr/+
small eye. (C) GMR-egr/+; Mkk4G680/+. Removing one copy of Mkk4 suppresses the small eye phenotype. (D) GMR-
egr/+; Mkk4
G680/Df6149
. Removing both copies of Mkk4 does hardly improve the suppression. (F) hep1; GMR-egr/+.
Males hemizygous mutant for a hypomorphic hep allele display a strong suppression of the small eye. (G) GMR-
egr/tub-Mkk4; Mkk4
G680
/+. A Mkk4 rescue transgene reverts the dominant suppression observed by loss of one copy
of Mkk4. (H) GMR-egr/UAS-Mkk4. Co-expression of Mkk4 has dominant negative effect on Eiger signal transduction.
(I) GMR-egr/UAS-Mkk4Asp. The same is true for Mkk4Asp. (J) GMR-hepCA/UAS-Mkk4 (25°). Co-expression of Mkk4
also suppresses the small eye phenotype induced by HepCA. (K) GMR-hepCA/UAS-Mkk4Asp (25°). Co-expression of
Mkk4
Asp does not suppress the small eye phenotype induced by HepCA. (L) GMR-hepCA/+ (18°). Weaker expression
of hepCA leads to a less severe small eye phenotype. (M) GMR-hepCA/+; Mkk4G587/G673 (18°). This phenotype is not
suppressed, even when both copies of Mkk4 are removed. (N) Indicated are the mutations introduced in Mkk4Asp and
Mkk4Mut.
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To confirm that Mkk4 indeed acts, like Hep, at the level of a MAPKK, epistasis experiments in
flies and cells as well as protein interaction studies were performed. The small eye phenotype
induced by expression of hepCA in the Drosophila eye (Figure 1L) is not suppressed by
removing one (not shown) or both copies of Mkk4 (Figure 1M) placing Mkk4 upstream or in
parallel to Hep. RNAi experiments in S2 cells place Mkk4 downstream of the MAPKKK
dTAK1 verifying Mkk4 to function as a classical MAPKK: expression of dTAK1 strongly
induces the activity of an AP1-luciferase-reporter in S2 cells (Figure 2A). RNAi against hep
and Mkk4 together significantly reduces this activity (Figure 2A). Single RNAi treatment
against either of the two kinases was not sufficient to reduce the luciferase signal, which
could be explained by the very strong induction obtained by expression of dTAK1 (Figure 2A).
In flies, lowering the dosage of either Hep or Mkk4 is sufficient to suppress the Eiger-induced
small eye phenotype (Figure 1D, and F). LPS-induced JNK phosphorylation in S2 cells, which
is widely used to mimick an innate immune response, is also sensitive to RNAi against either
hep or Mkk4 (Figure 2B), confirming previous reports indicating that both, Mkk4 and Hep, are
required in Drosophila innate immune response (Boutros et al., 2002; Chen et al., 2002). In
agreement with this the reduction in phosphorylated JNK levels is enhanced when both
kinases are targeted by RNAi at the same time (Figure 2B). This experiment also
demonstrates that RNAi against Mkk4 efficiently knocks down Mkk4 levels.
Figure 2  (A) RNAi against Mkk4 and hep together significantly reduces dTAK1-induced AP-1 reporter activity. (B)
RNAi against Mkk4 and/or hep reduces phosphorylated JNK levels induced by LPS. (C) In contrast to Hep and
HepCA, Mkk4 and Mkk4Asp do not induce AP-1 reporter activity on their own. (D) Mkk4 physically interacts with dTAK1
and Bsk.
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Further evidence suggesting that Mkk4 indeed acts as a MAPKK was obtained from protein
interaction studies. Co-immunoprecipitations revealed that Mkk4 physically interacts with its
upstream kinase dTAK1 as well as with its downstream kinase Bsk. When expressed in S2
cells, N-terminally HA tagged Mkk4 co-immunoprecipitated both, C-terminally FLAG tagged
dTAK1 and Bsk (Figure 2D).
In contrast to the intrinsic activity of HepCA (strong) and HepWT (weak), wild type Mkk4 does
not activate the JNK pathway when overexpressed in cells (Figure 2C) or in flies (not shown).
Interestingly, wild type Mkk4 has a dominant negative effect when co-expressed with Eiger
(Figure 1H) or HepCA (Figure 1J) in flies. This is probably due to its interaction with Bsk and
dTAK1. Co-expression of Mkk4 probably titrates away Bsk and dTAK1. In an attempt to
generate a constitutive active Mkk4 (Mkk4Asp), we introduced the Ser277Asp and
Thr281Asp mutations, which corresponds to the mutations that were introduced to generate
HepCA (Adachi-Yamada et al., 1999) (Figure 1N). Surprisingly, Mkk4Asp is not constitutive
active, either in flies (not shown) or in cells (Figure 2C), but also dominantly suppresses
GMR-egr (Figure 1I) but not GMR-hepCA (Figure 1K). This difference between Mkk4WT and
Mkk4Asp could be explained by assuming that Mkk4Asp is still able to bind to dTAK1 but no
longer binds to Bsk. Co-IP experiments to support this hypothesis remain to be done. A
kinase dead version of Mkk4 (Mkk4Mut) where mutations Ser227Ala and Thr281Val were
introduced (Figure 1N) behaved identical to Mkk4WT (not shown).
In this study we isolated for the first time mutations in Drosophila Mkk4. Our genetic and
biochemical experiments demonstrate a non-redundant role for Mkk4 as a MAPKK in the
Eiger pathway. It seems that in Drosophila both MAPKKs, Hep and Mkk4, are required to
induce JNK after TNF stimulation. Since Mkk4 mutants are homozygous viable and do not
display any obvious phenotype, we tested their behavior under certain stress conditions. We
did not observe any obvious effect under oxidative stress (Paraquat). hep1 hemizygous males
are reported to be hypersensitive to paraquat (Wang et al., 2003). Whether this sensitivity is
enhanced in hep1-Mkk4 double mutant males remains to be analyzed. Furthermore wing hairs
in Mkk4 mutants do not display any defect in planar cell polarity, a process that is also
regulated by JNK signaling (Klein and Mlodzik, 2005). Again hep1-Mkk4 double mutants
remain to be analyzed. Since there is evidence from cell culture experiments that both
JNKKs, Hep and Mkk4, are required for Drosophila innate immunity (Boutros et al., 2002;
Chen et al., 2002), we are currently analyzing whether homozygous Mkk4 mutants display
any innate immunity defect.
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4.7  Identification of Lilliputian and Characterization of its Role in
       Eiger Signaling
Manuscript in the format of a “Genetics Note” in preparation.
Lilliputian Cooperates with dJun and dFos to Mediate Eiger-Induced Transcription
Peter Geuking, Rajesh Narasimamurthy, Knud Nairz and Konrad Basler
Institut für Molekularbiologie, Universität Zürich, CH-8057 Zürich, Switzerland
ABSTRACT
Here we describe the identification of mutations in lilliputian (lilli), isolated in a screen for
suppressors of Eiger-induced apoptosis. Genetic evidence, supported by biochemical
interaction studies, suggests that the three transcription factors Lilli, dJun (Jra) and dFos
(Kayak) cooperatively mediate Eiger-induced transcription.
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In a screen for dominant suppressors of Eiger-induced apoptosis (Geuking et al., 2005) a
lethal complementation group, named L1 (G127, G377, G453, G500), was isolated. All four
alleles representing L1 dominantly suppress the Eiger-induced small eye phenotype (Figure
1B, C, and D). Genetic mapping relative to the GMR-Gal4 insertion revealed that
complementation group L1 is located on the left arm of the second chromosome. In order to
further narrow down the region of interest, a high resolution FLP (fragment length
polymorphism) mapping effort was employed (Zipperlen et al., 2005). For this purpose we
used FLPs present between the GMR-Gal4 chromosome and the reference chromosomes
FRT40 or EP2L. Analysis of recombinants generated between the reference chromosome
and the mutated GMR-Gal4 chromosome revealed that L1 is located between FLP 2L027
(23B6) and 2L033 (24C7) (Berger et al., 2001) (Figure 1A). In a next step deficiencies of this
region were tested for dominant suppression of the Eiger-induced small eye phenotype and
complementation of L1. Of analyzed deficiencies only Df(2L)C144 (22F3-4; 23C3-5)
suppressed Eiger-induced apoptosis (Figure 1E) and failed to complement all four L1 alleles,
suggesting that the gene affected in L1 is deleted in this deficiency. Using overlapping
deficiencies (Df(2L)Exel6008, Df(2L)Exel6277) (Parks et al., 2004) that complemented L1 and
failed to suppress the small eye phenotype (not shown), the candidate region could be
narrowed down to the proximal part of Df(2L)C144. This is also consistent with the FLP data,
which indicated that the mutations lie proximal to 2L027 (Figure 1A). We tested available loss
of function alleles of genes in this region applying the same criteria as described above.
Interestingly, mutations in lilliputian (lilli4U5, lilli15D1) (Dickson et al., 1996; Wittwer et al., 2001)
were able to suppress the small eye phenotype (although weaker than L1) and failed to
complement L1 (Figure 1F). To confirm that L1 represents lilli, the lilli coding region of the four
isolated alleles was sequenced, revealing molecular lesions in three of them (Table 1).
Results of epistasis experiments with a constitutive active form of Hep (HepCA) (Adachi-
Yamada et al., 1999) were consistent with a role for lilli downstream of hep. The small eye
phenotype induced by expression of hepCA is suppressed by removing one copy of lilli (Figure
1G, and H).
Allele DNA Level Protein Level
G127 AAGTAG Lys781STOP
G377 5’ splice site intron 6:
AG/GTAG/AT
-
G453 - -
G500 CAGTAG Gln861STOP
Table 1 Molecular lesions identified in lilli. G453 may carry a mutation
outside of the coding region.
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Figure 1  (A) Schematic represntation of the lilli locus. (B) GMR-Gal4/+ control eye. (C) GMR-egr/+ small eye. (D)-(F)
are in a GMR-egr (GMR-Gal4 UAS-egr) background. (D) GMR-egr/lilliG500. Removing one copy of lilli suppresses the
small eye phenotype. (E) GMR-egr/Df(2L)C144. Df(2L)C144 dominantly suppresses the small eye phenotype. (F)
GMR-egr/lilli
15D1
. A previously identified lilli allele also suppresses the small eye although weaker. (G) GMR-hepCA/+
(18°). Expression of hepCA also leads to a apoptotic small eye phenotype. (H) GMR-hepCA/lilli15D1 (18°). Removing
one copy of lilli also suppresses this phenotype. (I) RNAi against lilli reduces the dTAK1-induced AP-1 reporter
activity. (J) Also RNAi against djun or/and dfos reduces the activity of an AP-1 (pRN58) luciferase reporter. RNAi
against dispatched (disp) is used as a negative control. (K) Lilli physically interacts with dJun and dFos. * indicates a
non-specific band. Upper panel: short exposure. Lower panel: long exposure.
lilli encodes a large HMG box-containing transcription factor (1673aa) which has already been
implicated in several pathways such as the Dpp-, Wg-, Ras-, Raf- and growth regulating
pathways as well as in transcriptional regulation of cytoskeletal functions and embryonic
segmentation (DasGupta et al., 2005; Dickson et al., 1996; Greaves et al., 1999; Muller et al.,
2005; Rebay et al., 2000; Su et al., 2001; Tang et al., 2001a; Wittwer et al., 2001). lilli is the
single Drosophila homolog of the human FMR2/AF4-related gene family (Su et al., 2001;
Tang et al., 2001a; Wittwer et al., 2001). Mutations in these genes have been implicated in
Results – Lilliputian 41
human mental retardation and cancer (Chakrabarti and Davies, 1997; Gecz et al., 1997; Gecz
et al., 1996; Gu et al., 1992; Gu et al., 1996; Taki et al., 1999).
From mammalian studies it is known that HMG box-containing proteins like Tcf or Lef may
interact with other transcription factors such as AP-1 (Jun/Fos) (Nateri et al., 2005; Rivat et
al., 2003). As already mentioned in Geuking et al. (2005), djun was genetically confirmed to
be involved in Eiger signaling. Mosaic flies with eyes homozygous mutant for djun display a
suppression of the Eiger-induced small eye phenotype (not shown). In addition RNAi against
either djun, dfos or lilli reduces the activity of an AP-1-luciferase-reporter induced by dTAK1 in
Drosophila cells (Figure 1I, and J). Co-expression of a dominant negative version of dFos in
flies also suppresses Eiger-induced apoptosis (not shown). Overexpression of any of them
(djun, dfos, lilli) does not activate the pathway either in flies (not shown) or in cells. Co-
overexpression of combinantions or all three of them also failed to activate the AP1-
luciferase-reporter (Narasimamurthy, 2006). To test whether Lilli might cooperate with dJun
and dFos in order to transduce the Eiger signal, we tested whether Lilli physically interacts
with dJun or dFos. Interestingly, co-immunoprecipitations (IP) revealed a weak physical
interaction between Lilli-dJun and Lilli-dFos in dTAK1 stimulated S2 cells. HA tagged Lilli co-
immunoprecipitated with FLAG tagged dJun and dFos (Figure 1K). Interestingly the strong
interaction between dJun-dFos in stimulated cells is weakened when Lilli is co-expressed,
although lilli co-overexpression does not have a dominant negative effect on Eiger-induced
apoptosis. Whether this interaction is still observed in unstimulated cells remains to be tested.
Since lilli was identified in a number of GMR-based genetic screens, it remains a possibility,
that lilli is important for proper transcription from the GMR promoter (discussed in Tang et al.,
2001a). Based on our RNAi experiments in cells, where tubulin-Gal4 but not GMR-Gal4 is
used, and the physical interaction we observed between AP-1 and Lilli, we are confident that
Lilli’s influence on the GMR promoter is not the major contribution to the suppression of the
small eye phenotype we observe. In addition the small eye phenotype observed when either
UAS-hid or UAS-egfrDN is driven by GMR-Gal4 is not suppressed (not shown). Therefore we
conclude that Lilli is a true component of the Eiger pathway in Drosophila that cooperates with
dJun and dFos in target gene transcription. It will be interesting to find out whether a Lilli
related or any other HMG box-containing transcription factor is also involved in TNF-induced,
AP-1-mediated transcription in humans.
Although lilli has already been implicated in a number of processes, we provide the first
molecular partner for one of its functions. We think that Lilli has very pleiotropic functions and
possibly acts as a cofactor for a lot of different transcription factors (discussed in Tang et al.,
2001a). Whether its cooperativity with AP-1 is dedicated only to the Eiger pathway or is also
important in other AP-1-dependent processes, such as thorax- or dorsal closure, remains to
be determined.
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4.8  Recombination-Based “Complementation” Analysis
With the exception of the bsk and L1 lethal complementation groups, the thus far identified
genes are homozygous viable. Therefore we developed another genetic assay to determine
whether two suppressor mutations affect the same or different genes.
Two mutagenized chromosomes carrying independent suppressor mutations were allowed to
recombine in females. When crossing these virgins back to GMR-egr/CyO males, two
different scenarios are possible. First, the non-CyO progeny contains flies displaying small
and suppressed eye phenotypes (Figure 7b). This means that a recombination event was
able to bring the two suppressor mutations together on one chromosome, and at the same
time generated a non-mutant chromosome. However, if the two independent suppressor
mutations affect the same gene, such an event is very unlikely and the non-CyO progeny will
only consist of flies with a suppressed eye phenotype (Figure 7a).
This assay was applied for two groups of three suppressor mutations located on the third
chromosome. One group consisted of G467, G781 and G870 the other consisted of G599,
G602 and G698. These were put into the respective group based on their relative genetic
distance to RFP4, RFP15 and RFP5 (see Appendix). Recombination-based
“complementation” analysis revealed that all six of them affect different genes. In any tested
combination, non-CyO progeny with small eyes was obtained. Also in this analysis, the
relation between the numbers of flies with small or suppressed eye phenotype in theory gives
the relative genetic distance between the two independent suppressor mutations. But in our
experiments too few progeny was counted to obtain a statistically significant genetic distance.
Recombination-based "complementation" analysis
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Figure 7  Crossing scheme for “recombination-based complementation analysis”.
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4.9  Suppressor G870 Deletes Chromosomal Region 75C
Genetic rough mapping relative to RFP4, RFP15 and RFP5 revealed that the three
suppressor mutations G467, G781 and G870 roughly map to the region of the known pro-
apoptotic genes hid, rpr, grim and skl at cytological position 75C (Figure 8). To test whether
any of these three suppressor mutations affects a pro-apoptotic gene, a complementation
analysis with the lethal deficiency Df(3L)H99, which deletes hid, rpr and grim but not skl
(White et al., 1994) was conducted. Df(3L)H99 is known to suppress the small eye phenotype
(Moreno et al., 2002b). One of the three mutations, G870, failed to complement the lethality of
Df(3L)H99. Subsequently the coding region of the four pro-apoptotic genes was sequenced in
the G870 stock, and also in the G467 and G781 stocks because these probably harbor viable
mutations in one of the four genes. Since all three chromosomes (G476, G781, G870) are
homozygous lethal and therefore balanced with TM6b, it is likely to detect polymorphisms in
the coding sequence of any of the four genes analyzed. Surprisingly, sequence analysis did
not reveal molecular lesions in these genes in any of the stocks. Importantly however, in the
case of G870, not a single double peak (polymorphism) was detected in any of the
sequences analyzed. This lead to the hypothesis that G870 may carry a deletion at 75C and
that in our analysis only pieces of the TM6b chromosome were amplified and sequenced. In
order to confirm this hypothesis, further complementation tests with G870 were performed. In
addition to Df(3L)ED224 and Df(3L)ED225, which were isolated in the deficiency screen and
also delete genes at 75C, G870 also failed to complement the lethality of the small
deficiencies Df(3L)Exel6133 and Df(3L)Exel6134. These two deficiencies delete genes just
distal and proximal to the pro-apoptotic genes (Figure 8), consistent with the fact that
Df(3L)Exel6133 and Df(3L)Exel6134 do not suppress the Eiger-induced small eye phenotype.
Based on this complementation results we conclude that G870 indeed is a deletion that
removes not only hid, rpr, grim and skl but also more distal and proximal regions. A further
fine mapping of the breakpoints of Df(3L)G870 was not conducted. Df(3L)G870 represents
another validation for the screen setup. The fact that Df(3L)G870 deletes hid, rpr, grim and skl
combined with results from the “recombination-based complementation analysis” indicates
that G467 and G781, in theory, must lie in a region flanking Df(3L)G870.
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Figure 8  Overview over locus 75C where hid, rpr, grim and skl are located.
4.10  Df(3L)Exel6107
Df(3L)Exel6107 was isolated in the deficiency screen described earlier, but none of the
suppressor mutations isolated from the EMS screen mapped to the same region (64E). As
already mentioned, the suppression of the small eye phenotype observed with
Df(3L)Exel6107 could not be confirmed with two independent deficiencies (Df(3L)ZN47 and
Df(3L)CH20) that even extend the region deleted in Df(3L)Exel6107. This excluded the
possibility that the responsible gene may be very small or very weakly accessible by EMS.
Df(3L)Exel6107 was generated by FLP/FRT-mediated recombination between two XP-
elements (P{XP}d08114 and P{XP}d03136) which resulted in a w+-marked XP-element
(P{XP}Exel6107) inserted exactly at the breakpoint of the deficiency (Parks et al., 2004). The
fact that the suppressor present on the deficiency chromosome could not be separated from
this w+ marker (not shown) indicated that locus 64E is responsible for the observed
suppression. Since XP elements contain UAS sites (Parks et al., 2004), we thought that the
observed suppression of the small eye is not due to a deleted gene but may be due to a gene
proximal or distal to the deficiency that is co-expressed when crossed to the GMR-egr stock
(GMR-Gal4 UAS-egr). To test this hypothesis we thought to analyze the potential to suppress
the small eye phenotype of the two XP-insertions that were used to generate Df(3L)Exel6107.
Unfortunately P{XP}d08114 and P{XP}d03136 were not available as stocks. However, we
could test two other XP-insertions, P{XP}d07920 and P{XP}d03195, inserted in the same
intergenic region as P{XP}d08114 and P{XP}d03136, respectively. P{XP}d07920 is inserted
710bp upstream of P{XP}d08114 and P{XP}d03195 is inserted only 37bp upstream of
P{XP}d03136. Interestingly, P{XP}d03195, but not P{XP}d07920, also suppressed the Eiger-
Results 45
induced small eye phenotype. From this we concluded that indeed the UAS sites present in
P{XP}d03195 and P{XP}Exel6107 are probably responsible for the observed suppression.
Since P{XP}d07920 did not suppress the small eye, we concluded that the responsible gene
influenced by the UAS sites should lie proximal to P{XP}d03195.
CG13288 is the first gene located downstream (+5kb) of P{XP}d03195, that is in the right
orientation (Figure 9). CG13288 encodes an uncharacterized protein containing four
predicted transmembrane helices and no other known domains. Whether this gene is indeed
responsible for the suppression remains to be confirmed by expression of a UAS-CG13288
transgene. Since this gene is already quite far away from the UAS sites, another possibility is
that an unpredicted gene closer to P{XP}d03195 is responsible for the observed suppression.
Figure 9  Overview over XP-insertions and Df(3L)Exel6107 located at 64E-F.
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4.11  Overview Chromosome II + III
Figure 10 gives an overview about the chromosomal locations of the Eiger suppressors
identified in this study. Grey indicates either genetic markers used for mapping or genes
involved in the pathway that were not isolated from the screen, due to reasons discussed
earlier. Cs II: lilli (green), bsk (orange), dTAB2 (blue), GMR-Gal4 insertion (red), single hits
(black). Cs III: Mkk4 (blue); Single hits, Df(3L)Exel6107 and locus 75C in black.
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5  Discussion
5.1  The EMS Screen
With a very simple genetic setup a very powerful screen could be performed. In addition to
genes already known to be involved in the Eiger pathway, such as bsk, dTAK1 and hid, we
identified mutations in three genes that had not yet been implicated in Drosophila Eiger
signaling (dTAB2, Mkk4, lilli). Mutations in lilli have already been identified in other screens,
but no mutations affecting dTAB2 or Mkk4 were available to date. The high number of alleles
obtained in bsk, dTAB2, Mkk4 and also in the GMR-Gal4 transgene suggests that the screen
has reached complete saturation, at least for the second and third chromosome. However, it
is striking that for the largest gene identified, lilli (~5kb CDS), we only obtained four new
alleles. From a comparison of the molecular nature of the different lilli EMS alleles that were
tested (4U5, 15D1, G127, G377, G453, G500), there is no reason to assume that the four lilli
alleles identified in our screen are somehow stronger or have even a dominant negative
nature, although lilli4U5 and lilli15D1 had a weaker potential to suppress the Eiger-induced small
eye phenotype than L1. Observations by Wittwer et al. (2001) even classify lilli4U5 as a strong
null allele. One explanation for the low number of alleles obtained is, that the lilli locus is
weakly accessible for EMS. To confirm this hypothesis the number of flies screened, the
number of lilli alleles identified and the EMS concentrations used in the different screens in
which lilli mutants were found, could be compared.
Complete saturation would also mean, that in theory we should also have identified mutations
in hid, rpr, grim and skl, or at least in one of them. rpr, grim and skl have a very short CDS
(180-400bp) and therefore are rarely hit by EMS. The hid CDS, however, has approximately
the same size as the Mkk4 CDS (~1.2kb). It is therefore surprising that we identified 21
mutations in Mkk4, but isolated only one deletion uncovering the four pro-apopototic genes.
One reason for this could be the redundancy between these genes, meaning that removing
one copy of just one of the four pro-apoptotic genes in this region was not sufficient to get a
suppression that was above the phenotypic threshold level set in the screen.
Most of the suppressor mutations identified in the EMS screen could be assigned to a single
gene. There are only eight “single hits” left, which remain to be mapped (see Figure 10 and
Appendix). Following a FLP/SNP mapping approach (Berger et al., 2001; Martin et al., 2001;
Nairz et al., 2002; Zipperlen et al., 2005) it should be possible to map these suppressors in a
straight forward fashion. The crossing scheme for these approaches would be comparable to
the one applied for FLP mapping in this work. The identification of these genes may uncover
very interesting new components and signaling mechanisms of TNF signal transduction in
general.
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5.2  The Deficiency Screen
The deficiencies identified in the deficiency screen turned out to be extremely valuable as
tools to map the suppressor mutations obtained from the EMS screen. A major advantage of
the screened deficiencies is that they are molecularly precisely mapped and in an isogenic
background. Another very useful feature, especially of the Exelixis deficiencies, is that they
are rather small. The three Exelixis deficiencies identified in our screen delete only 20-27
genes, which dramatically reduced the number of candidate genes in each case. Using
overlapping deficiencies can also be helpful in order to further narrow down the region of
interest. Some of the Exelixis deficiencies were generated with elements containing UAS
sites (XP- and WH-elements) (Parks et al., 2004). In some cases these UAS sites are still
present after the recombination event. Depending on the genetic background in which a
screen is performed, these UAS sites can have an influence on the phenotype. It is very
important to be aware of this fact when using these deficiencies. The elements used to
generate the DrosDel deficiencies never contain UAS sites (RS3- and RS5-elements) (Ryder
et al., 2004).
For all the deficiencies identified in our screen the responsible gene or UAS-containing
element could be identified, proving that such a deficiency screen indeed can be very
powerful when combined with other approaches, like an EMS screen.
5.3  Final Model
Table 2 summarizes again all the deficiencies and genes that were identified in the process of
this work. Our current view of how the Eiger signal is transduced from the cell membrane to
the nucleus is depicted in Figure 11.
Deficiency Gene # of Alleles
- dTAK1 1
- bsk 10
Df(3L)ED224
Df(3L)ED225
hid, rpr,
grim, skl
1
(Df(3L)G870)
Df(2R)Exel6069 dTAB2 39
Df(3R)Exel6149
Df(3R)ED5296 Mkk4 21
Df(2L)C144 lilli 4
Df(3L)Exel6107 CG13288?* 1
- GMR-Gal4 21 (+5)
Table 2  Summary of deficiencies and genes identified in this work.
                              * not yet confirmed
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Figure 11  Current view of transduction of the Eiger signal from the membrane to the nucleus.
Mammalian MAPKKKs other than TAK1 (ASK1, MLK and MEKK1) have been implicated in
TNF-induced JNK activation as well (Chang and Karin, 2001). An observation that can be
explained by the number of different receptors existing in mammals: some of them might use
a different mechanism to induce JNK signaling. In mammals the TAK1-TAB2 module was first
implicated in Toll-induced JNK and NFB activation, but then also shown to be involved in
TNF-mediated induction of these pathways (Ishitani et al., 2003; Morlon et al., 2005; Takaesu
et al., 2000; Takaesu et al., 2001). So far there is no evidence that Eiger also induces NFB,
although predicted since it acts through the TAK1-TAB2 module, which is an activator of
NFB. The fact that the TAK1-TAB2 module is indeed required for the IMD (TLR) pathway in
Drosophila (D. Ferrandon, unpublished) and that Eiger solely acts through this module,
indicates that this is the primordial mechanism of TLR/TNF-induced JNK activation and that
other ways to induce TNF-mediated JNK activation probably arose later in evolution. In
addition it also seems that signaling mechanisms evolved together with Toll signaling, such
as the FADD-Caspase-8 module, may have been adopted by TNF signaling at later stages of
evolution (Moreno et al., 2002b).
It is an interesting observation that, in contrast to mammals, in Drosophila Mkk4 seems to be
strictly required for TNF-induced JNK activation. Elucidating other roles of Mkk4, not detected
in our experiments, by further characterization of the Mkk4 null alleles isolated in this work will
be an important step in finding the reasons for this difference. In addition it will be exciting to
elucidate whether TNF-induced mammalian AP-1 also requires co-factors similar to Lilli in
Drosophila.
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5.4  Physiological Functions of Eiger
A very important question remains: what are the funcions of TNF/Eiger in Drosophila? Indeed
very little is known about the physiological functions of egr. Flies homozygous mutant for egr
are viable and display no obvious phenotype (Igaki et al., 2002). Igaki et al. reported that the
observed JNK activity behind the morphogenetic furrow in Drosophila eye imaginal discs is
reduced in egr mutants (Igaki et al., 2002). However, this does not seem to have any
morphological or developmental consequences. Hence egr mutants have either a phenotype
that is too subtle to detect, or display a phenotype only under certain conditions. The only
condition reported so far where egr mutants display a phenotype is upon Salmonella
infection: flies homozygous mutant for egr have a delay in Salmonella-induced lethality
(Brandt et al., 2004). It is thought that Salmonella infection leads to a condition comparable to
the TNF-inducible metabolic collapse in vertebrates (Brandt et al., 2004), as a consequence
of this the flies die. Whether the observed delay in lethality is due to the lack of Eiger-induced
JNK activation remains to be confirmed by testing the effect in dTAK1, dTAB2 or Mkk4
mutants. Under other stress conditions such as bacterial or fungal infection, oxidative stress
or X-ray, egr mutants displayed no phenotype different from wildtype flies (see Appendix).
Also, generating a situation where egr mutant cells are confronted with heterozygous cells in
the Drosophila eye did not reveal any difference between mutant and control heterozygous
cells (not shown). In a process called “cell competition”, cells that proliferate faster than
neighboring cells actively kill the slower growing cells by activating JNK-mediated apoptosis
in these cells (Moreno et al., 2002a). Eiger would be the perfect signal sent from the faster
growing cells to the slower growing ones. Clones overexpressing brinker (brk) are eliminated
from the center of the wing imaginal disc by cell competition (Moreno et al., 2002a). In such
clones a clear upregulation of Eiger was detected by antibody staining (Moreno E.,
unpublished). Whether this upregulation can also be observed at the transcriptional level can
easily be addressed by using the egr-lacZ lines described in the Appendix. However, since
Eiger was observed to be upregulated in the dying cells and not in the surrounding cells, it
can’t be the signal that is sent out by the faster growing cells. One hypothesis is, that Eiger
acts in an autocrine fashion and mainly kills the cells that express egr. This is consistent with
the observation that clones overexpressing eiger only kill themselves and one row of
surrounding cells (Moreo E., unpublished), unlike a clone overexpressing a soluble form of
Eiger that can travel further (Narasimamurthy, 2006). This also indicates that under
overexpressing conditions Eiger is not always cleaved and remains on the membrane,
explaining its proposed partial autocrine action. This scenario implies that there must exist a
signal coming from the faster growing cells that induces Eiger in the slower growing cells.
However, in an egr mutant background brk overexpressing clones still died although slightly
slower. This could be explained by redundancy at the level of the inducer. It would be
interesting to test whether brk overexpressing clones behave differently in a dTAK1, dTAB2
or Mkk4 homozygous mutant background.
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The elucidation of the primordial function of TNF/Eiger in Drosophila will be a very interesting
task. The fact that lower organisms, such as C. elegans, do not encode a TNF homolog in
their genome makes it even more interesting to decipher the origins of the evolution of TNF.
5.5  Outlook
The identification of mutations in dTAB2 and Mkk4, for the first time, will allow us to
investigate the role of these ptoreins not only in Eiger signaling but, importantly, also in other
processes. The availability of these mutants will therefore be of high interest. Our main
interest is to decipher molecular mechanisms of TNF/Eiger signaling. An important next step
to achieve this goal will be to map the genes that are affected in the still uncharacterized
suppressor mutations (“single hits”) found in our screen. Possible other approaches to identify
new components or regulators of this pathway are: (1) an in vivo RNAi screen or (2) an in vivo
overexpression screen. For both screens the same genetic tool that was useful in this work
(GMR-Gal4 UAS-egr), could be applied. A collection of stocks, which will be available soon
(B. Dickson, unpublished) carrying UAS-hairpin constructs of all the predicted Drosophila
genes can easily be screened for suppressors of the small eye phenotype when crossed
against the GMR-egr stock. In order to identify negative components or regulators a similar
collection containing defined comparable UAS-insertions of every predicted gene could be
screened (J. Bischof, unpublished). Since the small eye phenotype is not suppressed in wgn
homozygous mutant flies, the two screens described in this work and the RNAi screen
mentioned above could be performed in a wgn homozygous mutant background. This
strategy would allow us to overcome the problem of possible redundancy at the level of the
receptor. The redundancy is suggested by the fact that the Eiger-induced small eye
phenotype is not suppressed in wgn homozygous mutant flies. Since it would be quite labour
intensive to filter out all the known components that would again be hit in such an EMS
screen, the most promising approach would be the above mentioned RNAi screen in a wgn
homozygous mutant background. In this way, every predicted gene could be tested and
depending on the efficiency of the RNAi line components that need more than 50% reduction
to suppress the small eye phenotype could also be identified. The identification and
characterization of further novel components or regulators may uncover important aspects of
this evolutionarily ancient signaling pathway that plays important roles in mammalian
development and disease.
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6  Appendix
6.1  EMS Alleles - 2nd Chromosome
Allele v/l Suppression Suppr. of
GMR-hep
CA
Affected gene, mutation,
comments
%rgd to
GMR-Gal4
FLP data
G56 (*) l very good no ?, no mutation in dTAB2 CDS 60(215/361)* 2R017
G58 (*) l very good dTAB2G71 no dTAB2 Gln119 -> STOP 21 (29/137)* 2R068?/109
G71 (*) l very good no dTAB2 Gln40 -> STOP 18 (37/120)* 2R096/109
G87 (*) l middle no ?, no mutation in dTAB2 CDS 9 (22/241)* 2R118/130
G127 (*) l very good lilli15D1,4U5 yes lilli Lys781 -> Stop 69 (62/92)* 2L
G147 (*) l very good - no mutation in dTAB2 CDS 3 (6/190)* Inversion?
G179 (*) l middle bskG258 yes bsk Ser127 -> Phe 124(105/85)* 2L
G211 (*) l very good dTAB2G71 no dTAB2 C769 -> G, N770 -> C 12 (24/193)* 2R096/109
G227 (*) v very good dTAB2G71 no dTAB2 Gln713 -> STOP 14 (34/240)* 2R109/83?
G245 (*) v very good dTAB2G71 no dTAB2 7bp deletion 23 (45/199)*  -
G253 (*) l very good dTAB2G71 no dTAB2 Gln544 -> STOP 19 (49/252)* 2R109/83?
G258 (*) l good yes bsk Trp232 -> STOP 84 (91/108)* 2L
G271 (*) l very good dTAB2G71 no dTAB2 Gln728 -> STOP 19 (51/259)* 2R109/83?
G275 (*) l very good dTAB2G71 no dTAB2 Gln581 -> STOP 19 (36/193)* 2R068?/109
G291 l total - GMR-Gal4 0 (0/810) -
G303 v good - GMR-Gal4, Inr not rescued 0 (0/1050) -
G497 l good - GMR-Gal4 0 (0/212) -
G532 l total - GMR-Gal4 0 (0/153) -
G560 l total - GMR-Gal4 0 (0/128) -
G562 l total - GMR-Gal4 0 (0/211) -
G578 l total - GMR-Gal4 0 (0/170) -
G581 l total - GMR-Gal4 0 (0/201) -
G638 l good - GMR-Gal4, Inr not rescued 0 (0/85) -
G639 l middle - GMR-Gal4, Inr not rescued 0 (0/87) -
G672 l total - GMR-Gal4 0 (0/338) -
G686 l good - GMR-Gal4 0 (0/212) -
G689 l total - GMR-Gal4 0 (0/462) -
G713 l good - GMR-Gal4 0 -
G769 l total - GMR-Gal4 0 -
G817 l total - GMR-Gal4 0 -
G840 l good - GMR-Gal4, Inr not rescued 0 -
G847 l very good - GMR-Gal4 0 -
G859 l total - GMR-Gal4 0 (0/603) -
G882 l total - GMR-Gal4 0 -
G918 v total - GMR-Gal4 0 -
G930 v total - GMR-Gal4 0 -
G943 v total - GMR-Gal4 0 -
G998 l total - GMR-Gal4 0 -
G1007 v good - GMR-Gal4, Inr not rescued 0 -
G1019 l good - GMR-Gal4 0 -
G290 l good bskG258 yes bsk Ser208 -> Phe 25 (77/311) -
G368 l good bskG258 yes bsk Gln115 -> STOP 33 (82/246) -
G400 l good bskG258 yes bsk Thr181 -> Ile (TPY) 31 (70/225) -
G418 l good bskG258 yes bsk 3’ end intron 3 AG -> AA 31 (112/362) -
G536 l middle bskG258 yes bsk Ser127 -> Phe - -
G577 l middle bskG258 yes bsk Ala143 -> Val - -
G688 l middle bskG258 yes bsk Arg308 -> Pro - -
G760 l middle bskG258 yes bsk Pro182 -> Ser (TPY) 32 (97/302) -
G635 v total dTAB2G71 no dTAB2 Arg209 -> STOP 2 (8/388) 2R096/109
G715 v very good dTAB2G71 no dTAB2 Trp767 -> STOP 2.1 (8/382) -
G489 l very good dTAB2G71 no dTAB2 Gln634 -> STOP 2.3 (22/948) -
G788 l good dTAB2G71 no dTAB2 Gln542 -> STOP 3.6 (13/362) -
G666 l good dTAB2G71 no dTAB2 Gln458 -> STOP 3.7 (16/431) -
G539 l good dTAB2G71 no dTAB2 284bp deletion 3.8 (38/996) -
G973 l middle dTAB2G71 no dTAB2 Gln107 -> STOP 3.8 (17/447) -
G734 l good dTAB2G71 no dTAB2 Gln486 -> STOP 3.9 (22/557) -
G585 l good dTAB2G71 no dTAB2 Gln317 -> STOP 4 (12/306) 2R051/109
G642 l good dTAB2G71 no dTAB2 In.2 GT->GA,P450->S 4 (14/358) -
G856 l middle - no mut. in TAB2, lethal/G790 4 (16/406) -
G421 l good dTAB2G71 no dTAB2 Gln224 -> STOP 4.1 (41/995) 2R068/109
G548 l good dTAB2G71 no dTAB2 Gln641 -> STOP 4.1 (38/921) -
G503 l good dTAB2G71 no dTAB2 Gln317 -> STOP 4.2 (35/837) -
G683 l good dTAB2G71 no dTAB2 Gln330 -> STOP 4.3 (12/282) -
G954 v good dTAB2G71 no dTAB2 Gln689 -> STOP 4.4 (19/428) -
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Allele v/l Suppression Suppr. of
GMR-hep
CA
Affected gene, mutation,
comments
%rgd to
GMR-Gal4
FLP data
G825 l good dTAB2G71 no dTAB2 53bp deletion 4.5 (23/507) -
G701 l good dTAB2G71 no dTAB2 Trp767 -> STOP 4.6 (20/434) -
G603 l good dTAB2G71 no dTAB2 Gln744 -> STOP 4.8 (26/542) -
G812 l good dTAB2G71 no dTAB2 Glnt20 -> STOP 4.9 (18/369) -
G576 l good dTAB2G71 no dTAB2 Gln66 -> STOP 5.3 (33/616) -
G545 v good dTAB2G71 no dTAB2 Gln712 -> STOP 5.5 (55/998) -
G520 v good dTAB2G71 no dTAB2 Trp767 -> STOP 6 (26/435) -
G552 l good dTAB2G71 no dTAB2 Gln486 -> STOP 6 (18/304) -
G746 l very good dTAB2G71 no dTAB2 Gln633 -> STOP 6 (24/403) -
G933 l good dTAB2G71 no dTAB2 3’end intron 3 AG->AA 6 (16/264) -
G440 l very good - no mutation in dTAB2 CDS 6.2 (46/742) 2R083/130
G824 l good dTAB2G71 no dTAB2 Trp767 -> STOP 6.3 (51/807) -
G829 l good dTAB2G71 no dTAB2 Gln731 -> STOP 6.6 (37/555) -
G981 v middle dTAB2G71 no dTAB2 L570 -> Q, D592 -> N 6.7 (26/388) -
G790 l middle - no mut. in TAB2, lethal/G856 6.9 (22/320) -
G928 v good dTAB2G71 no dTAB2 Gly794 -> Asp 6.9 (33/481) -
G867 l good dTAB2G71 no dTAB2 Arg233 -> STOP 7 (19/275) -
G609 l good dTAB2G71 no dTAB2 Gln216 -> STOP 7.6 (27/352) -
G623 l middle - ?, dTAB2 Gln779 -> His ?? 13 (50/388) 2R017/68
G745 l good - ? 28 (76/273) 2L143
G377 l good lilli15D1,4U5 yes lilli 5’ end intron 6 GT -> AT 29 (165/566) 2L027/33
G500 l middle lilli15D1,4U5 yes no mutation in lilli CDS 30 (60/197) 2L027/33
G453 l middle lilli15D1,4U5 yes lilli Gln861 -> STOP 36 (44/122) 2L027/33
v = stock homozygous viable
l = stock homozygous lethal
rgd = relative genetic distance
(*) = wt chromosome was mutated
* = rough mapping crossing scheme b)
6.2  EMS Alleles - 3rd Chromosome
Allele v/l Suppression Suppr. of
GMR-hep
CA
Affected gene, mut.,
comments
%rgd to
RFP4
%rgd to
RFP15
%rgd to
RFP5
G39 l good - Mkk4 Pro292 -> Leu 51 (37/72) 0.6 (1/163) -
G48 l good - Mkk4 Ala10 -> Val 36 (22/60) 3.1 (5/160) -
G136 l good - Mkk4 Pro252 -> Ser 44 (69/157) 0.8 (1/125) -
G201 l good - Mkk4 Pro249 -> Asn 52 (47/91) 1.0 (1/97) -
G262 l very good - Mkk4 Val361 -> Met 39 (60/154) 0.8 (2/223) -
G270 l very good - Mkk4 Pro325 -> Leu 39 (15/38) 0 (0/185) -
G343 l good - Mkk4 Val250 -> Met 44 (58/132) 2.7 (3/110) -
G344 l good no Mkk4 Arg154 -> STOP 47 (24/51) 0.6 (1/173) -
G356 l good - Mkk4 653bp ins. at Ser38 52 (62/120) 2.1 (3/142) -
G414 v good no Mkk4 Gln273 -> STOP 45 (65/143) 2.4 (4/167) -
G451 l middle - Mkk4 Val171 -> Met 47 (73/154) 1.8 (3/168) -
G467 l WEAK* Lost? yes? very close to G870!?! 58(123/212) 11(26/230) 28(58/206)
G504 l weak - Mkk4 Glu318 -> Lys 46 (56/122) 2.6 (5/192) -
G583 l middle - Mkk4 Pro292 -> Ser 50 (68/135) 2.0 (3/153) -
G587 v middle no Mkk4 Trp329 -> STOP - 0.5 (1/212) -
G599 l middle yes TACE 99D1? 53(103/194) 43(68/156) 25(20/80)
G602 l good yes TACE 99D1? 44(64/147) 68(24/35) 46(62/133)
G653 l middle - no mutation in Mkk4 CDS (21/48) (1/32) -
G657 l weak - Mkk4 Asp308 -> Asn 48 (29/62) 0.9 (2/212) -
G673 l middle no Mkk4 Q66->ST. ,F184->T 47 (74/156) 1.5 (3/194) -
G680 l middle - Mkk4 Gln341 -> STOP 42 (78/187) 1.0 (2/194) -
G698 l WEAK* Lost? no TACE 99D1? 45(112/249) 61(74/121) 42(50/118)
G781 l good yes? weak ?, no mut in Mkk4 CDS 38 (69/181) 14(16/118) 10
G863 l middle - Mkk4 Gly269 -> Asp 48 (83/173) 0.4 (1/223) -
G870 l good yes deletion at 75C - 19 (14/72) 25
G894 l middle - Mkk4 Val250 -> Asn 48 (63/131) 1.4 (3/217) -
G896 l weak - Mkk4? no PCR products - 1.1 (1/92) -
G993 l good - Mkk4 Asp168 -> Asn 46 (68/149) 0.5 (1/193) -
G1010 l middle - Mkk4 5'end intr.3 GT->AT 46 (96/210) 1.6 (3/182) -
v = stock homozygous viable
l = stock homozygous lethal
rgd = relative genetic distance
* = because of the very weak suppression, “rec.-based compl. analysis” and “rough mapping” is not very reliable!
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6.3  Tested Exelixis Deficiencies
BL#   Deficiency S BL#   Deficiency S BL#   Deficiency S B L#   Deficiency S
7488 Df(2L)Exel6001 - 7553 Df(2R)Exel6071 - 7624 Df(3R)Exel6145 w 7689 Df(3R)Exel6211 -
7489 Df(2L)Exel6002 - 7554 Df(2R)Exel6072 - 7625 Df(3R)Exel6146 - 7690 Df(3R)Exel6212 -
7490 Df(2L)Exel6003 - 7557 Df(2R)Exel6077 - 7626 Df(3R)Exel6147 - 7691 Df(3R)Exel6213 -
7491 Df(2L)Exel6004 - 7558 Df(2R)Exel6078 - 7627 Df(3R)Exel6148 - 7692 Df(3R)Exel6214 -
7492 Df(2L)Exel6005 - 7559 Df(2R)Exel6079 - 7628 Df(3R)Exel6149 s 7693 Df(3R)Exel6215 -
7493 Df(2L)Exel6007 - 7561 Df(2R)Exel6082 - 7629 Df(3R)Exel6150 - 7694 Df(3R)Exel6216 -
7494 Df(2L)Exel6008 - 7562 Df(3L)Exel6083 - 7630 Df(3R)Exel6151 - 7695 Df(3R)Exel6217 -
7495 Df(2L)Exel6009 - 7563 Df(3L)Exel6084 - 7631 Df(3R)Exel6152 - 7696 Df(3R)Exel6218 -
7496 Df(2L)Exel6010 - 7564 Df(3L)Exel6085 - 7632 Df(3R)Exel6153 - 7697 Df(3R)Exel6219 -
7497 Df(2L)Exel6011 - 7565 Df(3L)Exel6086 - 7633 Df(3R)Exel6154 - 7699 Df(1)Exel6221 -
7498 Df(2L)Exel6012 - 7566 Df(3L)Exel6087 - 7634 Df(3R)Exel6155 - 7700 Df(1)Exel6223 -
7499 Df(2L)Exel6013 - 7567 Df(3L)Exel6088 - 7635 Df(3R)Exel6156 - 7702 Df(1)Exel6225 -
7500 Df(2L)Exel6014 - 7568 Df(3L)Exel6089 - 7636 Df(3R)Exel6157 - 7703 Df(1)Exel6226 -
7501 Df(2L)Exel6015 - 7569 Df(3L)Exel6090 - 7637 Df(3R)Exel6158 - 7704 Df(1)Exel6227 -
7502 Df(2L)Exel6016 - 7570 Df(3L)Exel6091 - 7638 Df(3R)Exel6159 - 7705 Df(1)Exel6230 -
7503 Df(2L)Exel6017 - 7571 Df(3L)Exel6092 - 7639 Df(3R)Exel6160 - 7706 Df(1)Exel6231 -
7504 Df(2L)Exel6018 - 7572 Df(3L)Exel6093 - 7640 Df(3R)Exel6161 - 7707 Df(1)Exel6233 -
7505 Df(2L)Exel6021 - 7573 Df(3L)Exel6094 - 7641 Df(3R)Exel6162 - 7708 Df(1)Exel6234 -
7506 Df(2L)Exel6022 - 7574 Df(3L)Exel6095 w 7642 Df(3R)Exel6163 - 7709 Df(1)Exel6235 -
7507 Df(2L)Exel6024 - 7575 Df(3L)Exel6096 - 7643 Df(3R)Exel6164 - 7710 Df(1)Exel6236 -
7508 Df(2L)Exel6025 - 7576 Df(3L)Exel6097 - 7644 Df(3R)Exel6165 - 7711 Df(1)Exel6237 -
7510 Df(2L)Exel6027 - 7577 Df(3L)Exel6098 - 7645 Df(3R)Exel6166 w 7712 Df(1)Exel6238 -
7511 Df(2L)Exel6028 w 7578 Df(3L)Exel6099 - 7646 Df(3R)Exel6167 w 7713 Df(1)Exel6239 -
7512 Df(2L)Exel6029 - 7580 Df(3L)Exel6101 - 7647 Df(3R)Exel6168 - 7714 Df(1)Exel6240 -
7513 Df(2L)Exel6030 - 7581 Df(3L)Exel6102 - 7648 Df(3R)Exel6169 - 7715 Df(1)Exel6241 -
7514 Df(2L)Exel6031 - 7582 Df(3L)Exel6103 - 7649 Df(3R)Exel6170 - 7716 Df(1)Exel6242 -
7515 Df(2L)Exel6032 - 7583 Df(3L)Exel6104 - 7650 Df(3R)Exel6171 - 7717 Df(1)Exel6244 -
7516 Df(2L)Exel6033 - 7584 Df(3L)Exel6105 - 7651 Df(3R)Exel6172 - 7718 Df(1)Exel6245 -
7517 Df(2L)Exel6034 - 7585 Df(3L)Exel6106 - 7652 Df(3R)Exel6173 - 7719 Df(1)Exel6248 -
7518 Df(2L)Exel6035 - 7586 Df(3L)Exel6107 m 7653 Df(3R)Exel6174 - 7720 Df(1)Exel6251 -
7519 Df(2L)Exel6036 - 7587 Df(3L)Exel6108 - 7654 Df(3R)Exel6175 - 7721 Df(1)Exel6253 -
7521 Df(2L)Exel6038 - 7588 Df(3L)Exel6109 - 7655 Df(3R)Exel6176 - 7722 Df(1)Exel6254 -
7522 Df(2L)Exel6039 - 7589 Df(3L)Exel6110 - 7658 Df(3R)Exel6179 - 7723 Df(1)Exel6255 -
7523 Df(2L)Exel6041 - 7591 Df(3L)Exel6112 w 7659 Df(3R)Exel6180 - 7724 Df(2L)Exel6256 -
7524 Df(2L)Exel6042 - 7593 Df(3L)Exel6114 - 7660 Df(3R)Exel6181 - 7726 Df(3R)Exel6259 -
7525 Df(2L)Exel6043 - 7594 Df(3L)Exel6115 - 7661 Df(3R)Exel6182 - 7729 Df(3L)Exel6262 -
7526 Df(2L)Exel6044 - 7595 Df(3L)Exel6116 - 7662 Df(3R)Exel6183 - 7730 Df(3R)Exel6263 -
7527 Df(2L)Exel6045 - 7596 Df(3L)Exel6117 - 7663 Df(3R)Exel6184 - 7731 Df(3R)Exel6264 -
7528 Df(2L)Exel6046 - 7597 Df(3L)Exel6118 - 7664 Df(3R)Exel6185 - 7732 Df(3R)Exel6265 -
7529 Df(2L)Exel6047 - 7598 Df(3L)Exel6119 - 7665 Df(3R)Exel6186 - 7734 Df(3R)Exel6267 -
7530 Df(2L)Exel6048 - 7599 Df(3L)Exel6120 w 7666 Df(3R)Exel6187 - 7736 Df(3R)Exel6269 -
7531 Df(2L)Exel6049 - 7600 Df(3L)Exel6121 - 7667 Df(3R)Exel6188 - 7737 Df(3R)Exel6270 -
7532 Df(2R)Exel6050 - 7601 Df(3L)Exel6122 w 7668 Df(3R)Exel6189 - 7739 Df(3R)Exel6272 -
7533 Df(2R)Exel6051 - 7602 Df(3L)Exel6123 - 7669 Df(3R)Exel6190 - 7740 Df(3R)Exel6273 -
7534 Df(2R)Exel6052 - 7604 Df(3L)Exel6125 - 7670 Df(3R)Exel6191 - 7741 Df(3R)Exel6274 -
7535 Df(2R)Exel6053 - 7605 Df(3L)Exel6126 - 7671 Df(3R)Exel6192 w 7742 Df(3R)Exel6275 -
7536 Df(2R)Exel6054 - 7606 Df(3L)Exel6127 - 7672 Df(3R)Exel6193 - 7743 Df(3R)Exel6276 -
7537 Df(2R)Exel6055 - 7607 Df(3L)Exel6128 w 7673 Df(3R)Exel6194 - 7744 Df(2L)Exel6277 -
7538 Df(2R)Exel6056 - 7608 Df(3L)Exel6129 - 7674 Df(3R)Exel6195 - 7745 Df(3L)Exel6279 -
7539 Df(2R)Exel6057 - 7609 Df(3L)Exel6130 - 7675 Df(3R)Exel6196 - 7746 Df(3R)Exel6280 -
7540 Df(2R)Exel6058 - 7610 Df(3L)Exel6131 - 7676 Df(3R)Exel6197 - 7747 Df(3R)Exel6282 -
7541 Df(2R)Exel6059 - 7611 Df(3L)Exel6132 - 7677 Df(3R)Exel6198 - 7748 Df(2R)Exel6283 -
7542 Df(2R)Exel6060 - 7612 Df(3L)Exel6133 - 7678 Df(3R)Exel6199 - 7749 Df(2R)Exel6284 -
7543 Df(2R)Exel6061 - 7613 Df(3L)Exel6134 - 7679 Df(3R)Exel6200 - 7750 Df(2R)Exel6285 -
7544 Df(2R)Exel6062 - 7614 Df(3L)Exel6135 - 7680 Df(3R)Exel6201 - 7752 Df(3R)Exel6288 -
7545 Df(2R)Exel6063 - 7615 Df(3L)Exel6136 - 7681 Df(3R)Exel6202 - 7753 Df(1)Exel6290 -
7546 Df(2R)Exel6064 - 7616 Df(3L)Exel6137 - 7682 Df(3R)Exel6203 - 7754 Df(1)Exel6291 -
7547 Df(2R)Exel6065 - 7617 Df(3L)Exel6138 - 7683 Df(3R)Exel6204 - 7759 Df(1)Exel9050 -
7548 Df(2R)Exel6066 - 7619 Df(3R)Exel6140 - 7684 Df(3R)Exel6205 - 7760 Df(1)Exel9053 -
7549 Df(2R)Exel6067 - 7620 Df(3R)Exel6141 - 7685 Df(3R)Exel6206 - 7761 Df(1)Exel7463 -
7550 Df(2R)Exel6068 - 7621 Df(3R)Exel6142 - 7686 Df(3R)Exel6208 - 7762 Df(1)Exel9051 -
7551 Df(2R)Exel6069 s 7622 Df(3R)Exel6143 w 7687 Df(3R)Exel6209 - 7763 Df(1)Exel9054 -
7552 Df(2R)Exel6070 - 7623 Df(3R)Exel6144 - 7688 Df(3R)Exel6210 - 7764 Df(1)Exel7464 -
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BL#   Deficiency S BL#   Deficiency S BL#   Deficiency S B L#   Deficiency S
7765 Df(1)Exel9067 - 7840 Df(2L)Exel8038 - 7923 Df(3L)Exel9058 - 7991 Df(3R)Exel9013 -
7766 Df(1)Exel7465 - 7841 Df(2L)Exel9033 - 7924 Df(3L)Exel9001 - 7992 Df(3R)Exel9014 -
7767 Df(1)Exel9068 - 7842 Df(2L)Exel9063 - 7925 Df(3L)Exel9028 - 7993 Df(3R)Exel8178 -
7768 Df(1)Exel7468 - 7843 Df(2L)Exel7071 - 7926 Df(3L)Exel7208 - 7994 Df(3R)Exel9056 -
7769 Df(1)Exel8196 - 7844 Df(2L)Exel7072 - 7927 Df(3L)Exel7210 - 7995 Df(3R)Exel9025 -
7770 Df(1)Exel9049 - 7846 Df(2L)Exel8039 - 7928 Df(3L)Exel8101 - 7997 Df(3R)Exel7378 -
7771 Df(1)Exel9052 - 7847 Df(2L)Exel8040 - 7929 Df(3L)Exel8104 -
7772 Df(2L)Exel7002 - 7848 Df(2L)Exel7075 - 7930 Df(3L)Exel9034 -
7774 Df(2L)Exel8003 - 7850 Df(2L)Exel7077 - 7931 Df(3R)Exel7315 -
7775 Df(2L)Exel7005 - 7851 Df(2L)Exel7078 - 7932 Df(3R)Exel7317 -
7776 Df(2L)Exel7006 - 7852 Df(2L)Exel7079 - 7933 Df(3L)Exel9048 -
7777 Df(2L)Exel8004 - 7853 Df(2L)Exel7080 - 7934 Df(3L)Exel9017 -
7778 Df(2L)Exel7007 - 7855 Df(2L)Exel7081 - 7935 Df(3L)Exel9002 -
7779 Df(2L)Exel8005 - 7858 Df(2R)Exel7092 - 7936 Df(3L)Exel9003 -
7780 Df(2L)Exel7008 - 7859 Df(2R)Exel7094 - 7937 Df(3L)Exel9004 -
7782 Df(2L)Exel7010 - 7860 Df(2R)Exel7095 - 7938 Df(3L)Exel7253 -
7783 Df(2L)Exel7011 - 7862 Df(2R)Exel7096 - 7940 Df(3L)Exel9006 -
7784 Df(2L)Exel7014 - 7863 Df(2R)Exel8047 - 7941 Df(3L)Exel9046 -
7785 Df(2L)Exel7015 - 7864 Df(2R)Exel7098 - 7942 Df(3L)Exel9007 -
7786 Df(2L)Exel8008 - 7866 Df(2R)Exel8049 - 7943 Df(3L)Exel9008 -
7787 Df(2L)Exel7016 - 7867 Df(2R)Exel9016 - 7944 Df(3L)Exel9009 -
7789 Df(2L)Exel7018 - 7869 Df(2R)Exel7121 - 7945 Df(3L)Exel9011 -
7790 Df(2L)Exel8010 - 7870 Df(2R)Exel7123 - 7946 Df(3L)Exel9061 -
7792 Df(2L)Exel9062 - 7871 Df(2R)Exel8057 - 7947 Df(3L)Exel9045 -
7793 Df(2L)Exel8012 - 7872 Df(2R)Exel7124 - 7948 Df(3R)Exel7357 -
7794 Df(2L)Exel7022 - 7873 Df(2R)Exel7128 - 7949 Df(3L)Exel9065 -
7795 Df(2L)Exel702 - 7875 Df(2R)Exel7130 - 7950 Df(3L)Exel9066 -
7796 Df(2L)Exel8013 - 7876 Df(2R)Exel7131 - 7951 Df(3R)Exel9029 -
7797 Df(2L)Exel7023 - 7877 Df(2R)Exel8059 - 7952 Df(3R)Exel7283 -
7798 Df(2L)Exel8016 - 7879 Df(2R)Exel7135 - 7953 Df(3R)Exel7284 -
7799 Df(2L)Exel7024 - 7880 Df(2R)Exel9015 - 7954 Df(3R)Exel8143 -
7800 Df(2L)Exel9038 - 7881 Df(2R)Exel9026 - 7955 Df(3R)Exel9036 -
7801 Df(2L)Exel7027 - 7882 Df(2R)Exel7137 - 7956 Df(3R)Exel7305 -
7802 Df(2L)Exel7029 - 7883 Df(2R)Exel7138 - 7957 Df(3R)Exel7306 -
7803 Df(2L)Exel8019 - 7884 Df(2R)Exel7139 - 7958 Df(3R)Exel8152 -
7804 Df(2L)Exel7031 - 7885 Df(2R)Exel9060 - 7959 Df(3R)Exel7308 -
7805 Df(2L)Exel9031 - 7886 Df(2R)Exel7142 - 7960 Df(3R)Exel7309 -
7807 Df(2L)Exel7034 - 7887 Df(2R)Exel7145 - 7961 Df(3R)Exel8154 -
7808 Df(2L)Exel8021 - 7888 Df(2R)Exel7144 - 7962 Df(3R)Exel9018 -
7809 Df(2L)Exel7038 - 7890 Df(2R)Exel7149 - 7963 Df(3R)Exel8153 -
7810 Df(2L)Exel7039 - 7891 Df(2R)Exel7150 - 7964 Df(3R)Exel9019 -
7811 Df(2L)Exel7040 - 7893 Df(2R)Exel7153 - 7965 Df(3R)Exel7310 -
7812 Df(2L)Exel7042 - 7894 Df(2R)Exel7157 - 7966 Df(3R)Exel7312 -
7813 Df(2L)Exel8022 - 7895 Df(2R)Exel7158 - 7967 Df(3R)Exel8155 -
7814 Df(2L)Exel9064 - 7896 Df(2R)Exel7162 - 7968 Df(3R)Exel7313 -
7815 Df(2L)Exel9040 - 7897 Df(2R)Exel7163 - 7969 Df(3R)Exel7314 -
7816 Df(2L)Exel7043 - 7898 Df(2R)Exel7164 - 7970 Df(3R)Exel7316 -
7817 Df(2L)Exel8024 - 7900 Df(2R)Exel7169 - 7972 Df(3R)Exel7318 -
7818 Df(2L)Exel9032 - 7901 Df(2R)Exel7170 - 7973 Df(3R)Exel8157 -
7819 Df(2L)Exel7046 - 7902 Df(2R)Exel7171 - 7974 Df(3R)Exel8158 -
7820 Df(2L)Exel8026 - 7903 Df(2R)Exel7173 - 7975 Df(3R)Exel7320 -
7821 Df(2L)Exel7049 - 7904 Df(2R)Exel7174 - 7976 Df(3R)Exel8159 -
7822 Df(2L)Exel8028 - 7905 Df(2R)Exel7176 - 7977 Df(3R)Exel7321 -
7823 Df(2L)Exel7055 - 7906 Df(2R)Exel7177 - 7978 Df(3R)Exel8160 -
7826 Df(2L)Exel7059 - 7909 Df(2R)Exel7180 - 7980 Df(3R)Exel7326 -
7828 Df(2L)Exel8033 - 7910 Df(2R)Exel7182 - 7981 Df(3R)Exel8162 -
7830 Df(2L)Exel8034 - 7912 Df(2R)Exel7184 - 7982 Df(3R)Exel7327 -
7831 Df(2L)Exel7063 - 7913 Df(2R)Exel9043 - 7983 Df(3R)Exel7328 -
7833 Df(2L)Exel7066 - 7914 Df(2R)Exel7185 - 7984 Df(3R)Exel7329 -
7834 Df(2L)Exel7067 - 7916 Df(2L)Exel8056 - 7985 Df(3R)Exel7330 -
7835 Df(2L)Exel8036 - 7918 Df(3R)Exel8194 - 7986 Df(3R)Exel9055 -
7836 Df(2L)Exel9044 - 7919 Df(3R)Exel7379 - 7987 Df(3R)Exel8163 -
7837 Df(2L)Exel7069 - 7920 Df(3L)Exel9057 - 7988 Df(3R)Exel8165 -
7838 Df(2L)Exel7068 - 7921 Df(3L)Exel9000 - 7989 Df(3R)Exel9030 -
7839 Df(2L)Exel7070 - 7922 Df(3L)Exel8098 - 7990 Df(3R)Exel9012 -
BL# = Bloomington stock #
S = Suppression?
- = no suppression
w = weak
m = medium
s  = strong
When loss of function
alleles available, these
deficiencies were confirmed
to be correct.
(by the Bloomington
Drosophila Stock Center)
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6.4  Tested DrosDel Deficiencies
Deficiency S Deficiency S Deficiency S Deficiency S
Df(1)ED404 - Df(2L)ED49 - Df(3L)ED4238 - Df(3R)ED5221 -
Df(1)ED418 - Df(2L)ED499 - Df(3L)ED4256 - Df(3R)ED5223 -
Df(1)ED429 - Df(2L)ED508 - Df(3L)ED4284 - Df(3R)ED5230 -
Df(1)ED6443 - Df(2L)ED5878 - Df(3L)ED4287 - Df(3R)ED5296 m
Df(1)ED6574 - Df(2L)ED606 - Df(3L)ED4288 - Df(3R)ED5300 -
Df(1)ED6630 - Df(2L)ED62 - Df(3L)ED4293 - Df(3R)ED5516 -
Df(1)ED6712 - Df(2L)ED623 - Df(3L)ED4342 - Df(3R)ED5558 -
Df(1)ED6720 - Df(2L)ED647 - Df(3L)ED4408 w Df(3R)ED5608 -
Df(1)ED6829 - Df(2L)ED680 - Df(3L)ED4415 - Df(3R)ED5622 -
Df(1)ED6906 - Df(2L)ED695 - Df(3L)ED4416 - Df(3R)ED5705 -
Df(1)ED7005 - Df(2L)ED700 - Df(3L)ED4421 - Df(3R)ED5785 -
Df(1)ED7153 - Df(2L)ED746 - Df(3L)ED4470 - Df(3R)ED5911 -
Df(1)ED7217 - Df(2L)ED784 - Df(3L)ED4483 - Df(3R)ED5938 -
Df(1)ED7229 - Df(2L)ED80 - Df(3L)ED4486 - Df(3R)ED5942 -
Df(1)ED7374 w Df(2L)ED800 - Df(3L)ED4502 - Df(3R)ED6076 -
Df(1)ED7413 - Df(2L)ED87 - Df(3L)ED4543 - Df(3R)ED6085 -
Df(2L)ED1050 - Df(2L)ED929 - Df(3L)ED4674 - Df(3R)ED6103 -
Df(2L)ED1109 - Df(2R)ED1 - Df(3L)ED4685 - Df(3R)ED6232 -
Df(2L)ED1200 - Df(2R)ED1552 - Df(3L)ED4782 - Df(3R)ED6237 -
Df(2L)ED1231 - Df(2R)ED1612 - Df(3L)ED4786 - Df(3R)ED6242 -
Df(2L)ED1303 - Df(2R)ED3923 - Df(3L)ED4789 - Df(3R)ED6310 -
Df(2L)ED1305 - Df(3L)ED201 - Df(3L)ED4799 - Df(3R)ED7665 -
Df(2L)ED134 - Df(3L)ED202 - Df(3L)ED4978 -
Df(2L)ED136 - Df(3L)ED207 - Df(3L)ED5017 -
Df(2L)ED1466 - Df(3L)ED208 - Df(3R)ED2 -
Df(2L)ED19 - Df(3L)ED210 - Df(3R)ED5020 -
Df(2L)ED270 - Df(3L)ED211 - Df(3R)ED5021 -
Df(2L)ED273 - Df(3L)ED212 - Df(3R)ED5046 -
Df(2L)ED279 - Df(3L)ED215 - Df(3R)ED5066 -
Df(2L)ED284 - Df(3L)ED217 - Df(3R)ED5071 -
Df(2L)ED285 - Df(3L)ED218 - Df(3R)ED5092 -
Df(2L)ED292 - Df(3L)ED219 - Df(3R)ED5095 -
Df(2L)ED299 - Df(3L)ED220 - Df(3R)ED5100 -
Df(2L)ED343 - Df(3L)ED223 - Df(3R)ED5138 -
Df(2L)ED353 - Df(3L)ED224 m Df(3R)ED5142 -
Df(2L)ED354 - Df(3L)ED225 m Df(3R)ED5147 -
Df(2L)ED369 - Df(3L)ED228 - Df(3R)ED5156 -
Df(2L)ED384 - Df(3L)ED230 - Df(3R)ED5177 -
Df(2L)ED475 - Df(3L)ED231 - Df(3R)ED5196 -
Df(2L)ED479 - Df(3L)ED4079 - Df(3R)ED5220 -
S = Suppression?
- = no suppression
w = weak
m = medium
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6.5  Genetic Evidence For a Role of djun and dfos in Eiger
       Signaling
Since loss of djun and dfos does not dominantly suppress the Eiger-induced small eye
phenotype, we tested their recessive potential to do so. For this purpose we used the eyflp
system to generate flies that have djun or dfos homozygous mutant heads but are otherwise
heterozygous. As a control we also generated such animals with a bsk mutant allele (bsk1),
although bsk already dominantly suppresses the small eye. Since djun and bsk are located
on the second chromosome, we needed to use a combination of GMR-Gal4 and UAS-egr on
the third chromosome (Figure 12A, and B), which is weaker and more variable than the
combination of insertions on the second chromosome (Figure 12G). Mosaic flies with
homozygous eyes mutant for bsk or djun display a suppression of this weak small eye
phenotype (Figure 12C, and E). The eye size in control bsk or djun eyeflp clones is not
affected (Figure 12D, and F). Co-expression of a dominant negative form of dFos (dFosbZIP)
also suppresses the small eye phenotype (Figure 12H). Since the eyes of flies that express
GMR-egr and are homozygous mutant for dfos exhibited a very distorted eye (not shown) this
experiment was not informative. Moreover, control dfos eyflp clones could not be obtained.
Second hits on the dfos mutant chromosome are a possible explanation for this observation.
Figure 12  (A)+(B) GMR-Gal4(III) UAS-egr(III)/+. The combination of GMR-Gal4 and UAS-egr on the third
chromosome is weaker and quite variable compared to the one on the second chromosome. (C) eyflp; FRT bsk1/FRT
cl; GMR-egr(III). Mosaic flies with eyes homozygous mutant for bsk display a good suppression of the Eiger-induced
small eye phenotype. (D) eyflp; FRT bsk1/FRT cl; +. bsk control eyflp clone (E) eyflp; FRT jun-/FRT cl; GMR-egr(III).
Mosaic flies with eyes homozygous mutant for djun also display a good suppression of the Eiger-induced small eye
phenotype. (F) eyflp; FRT djun-/FRT cl; +. jun control eyflp clones (G) Strong GMR-Gal4 UAS-egr combination on the
second chromosome. (H) GMR-egr/+; UAS-fosbZIP/+. Co-expression of a dominant negative version of dFos
suppresses the small eye phenotype.
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6.6  Characterization of an egr-lacZ Reporter in vivo
In order to generate an egr-lacZ reporter line, transgenic flies were generated carrying a 10kb
fragment of the egr locus where the lacZ coding region has been inserted at the position of
the ATG of the egr gene (714-lacZ, D. Hengartner, unpublished). Imaginal discs from these
lines displayed a lacZ expression pattern identical to the egr RNA in situ expression pattern,
indicating that all the regulatory sequences required for egr imaginal disc expression under
normal conditions are included in this 10kb fragment (Figure 13). To further narrow down the
regulatory region of egr, sub-fragments (pDA679, pDA690, pDA676, pDA675, D. Hengartner,
unpublished) of this 10kb fragment were cloned into a lacZ-containing transformation vector
(pX27). Of the four fragments tested, only one, pDA679, produced a strong very specific egr-
like expression pattern in imaginal discs (Figure 13). These egr reporter lines may be very
useful when studying the transcriptional regulation of egr. Since no eye- or wing-phenotype
could be observed in egr mutants, the physiological importance of the observed expression
pattern remains to be elucidated.
Figure 13  Schematic overview over the egr locus and the fragments used to generate an egr-lacZ reporter line.
5000 5500 6000 6500 7000 7500 8000 8500 9000 9500 10000 10500 11000 11500 12000 12500 13000 13500 14000 14500 15000
eiger
ATG
714-lacZ
two copies!
pDA679-lacZ pDA690-lacZ pDA676-lacZ pDA675-lacZ
egr RNA in situ
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6.7  Eiger Overexpression in the Embryo
In this study we used the potential of Eiger to induce JNK-mediated apoptosis in Drosophila
imaginal discs. To test whether Eiger also induces apoptosis at embryonic stages, UAS-egr
was expressed under the control of prd-Gal4. Surprisingly such flies survived to adulthood
without any morphological defects (besides a very mild phenotype at the tip of the wing due to
the leakiness of the Gal4 driver) indicating that Eiger is not able to induce apoptosis in the
embryo. To test whether this is due to the failure of Eiger to induce JNK in embryos or due to
a different output of JNK signaling, JNK activation was measured by puc-lacZ staining. A
subset of the progeny of the cross depicted in Figure 14 are embryos expressing UAS-egr
under the control of prd-Gal4 that also carry the puc-lacZ reporter. All embryos that displayed
a lacZ staining reflected only the endogenous puc expression that is required in the process
of dorsal closure. A prd-like expression pattern in stripes was never observed. Since adult
flies expressing UAS-egr under the control of prd-Gal4 were obtained, this is not due to the
lack of such embryos, but indeed indicated that Eiger fails to induce JNK activation in the
embryo. This is consistent with the observation that also in embryo-derived S2- or Kc-cells
Eiger does not induce JNK phosphorylation (Narasimamurthy, 2006), which may be due to
the lack of expression of critical pathway components in the embryonic stage.
Figure 14  Expression of UAS-egr under the control of prd-Gal4 does not induce ectopic JNK activation in the
embryo.
yw ; UAS-egr/CyO ; prd-Gal4/TM6b   X   yw ;  + ;  pucZ(E69)/TM6b
Collect embryos and stain against Beta-gal
Some embryos have the following genotype:
yw ; UAS-egr/+ ; prd-Gal4/pucZ
pucZ Staining by Britta Hartmann, Basel
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6.8  Attempts to Generate a hid-lacZ Reporter
Since the pro-apoptotic gene hid was shown to be transcriptionally upregulated in eye discs
expressing UAS-egr under the control of GMR-Gal4 (Moreno et al., 2002b), we were
interested in identifying the regulatory sequences that are responsive to the Eiger signal. For
this purpose two 5kb fragments covering 10kb upstream of the hid translational start and two
5kb fragments covering the first large intron were cloned into a lacZ-containing transformation
vector (pX27). None of these reporter fragments displayed a lacZ staining either in a wildtype
or in a GMR-egr background (not shown). Interestingly other attempts to generate a similar
reporter line also failed (Moon et al., 2005), suggesting that the hid regulatory region may be
very complex, which is also supported by the fact that the hid 5’UTR (~10kb) and first exon
(~10kb) are very large. Another aspect is, that locus 75C, where hid is located, contains three
further pro-apoptotic genes (rpr, grim, skl) of which at least one is also involved in Eiger-
induced apoptosis (see Chapter 4.2). This raises the possibility that not only hid but the whole
locus is under complex transcriptional regulation.
6.9  eiger Mutants Under Different Stress Conditions
egr mutants are homozygous viable and do not display any obvious phenotype. As discussed
in Chapter 5.4 this could be due to the fact that the phenotype is very subtle and therefore
hard to detect or that a phenotype will only be observed under certain conditions. So far only
one such condition was reported to have an effect. egr mutants have a delay in lethality
caused by Salmonella infection (Brandt et al., 2004), which is not dependent on the canonical
innate immunity pathways Toll and IMD. Whether this is due to the lack of Eiger-mediated
JNK induction remains to be confirmed by testing flies homozygous mutant for dTAK1, dTAB2
or Mkk4. The Toll- and IMD-dependent innate immune response to gram-positive/negative
bacteria or fungi is not affected in egr mutants (B. Lemaitre, personal communication). Since
Eiger induces JNK and subsequent apoptosis, we also tested whether egr mutants are more
susceptible to oxidative stress, which is dependent on JNK signaling (Wang et al., 2003), or
whether they have a reduced capability to mediate X-ray-induced apoptosis. No difference in
the response to Paraquat (oxidative stress) could be observed in comparison to wildtype flies
(not shown). Similarly in response to X-ray treatment (5000 rad) cleavage of caspase-3 is not
affected (Figure 15). Moreover egr is not transcriptionally upregulated in response to X-ray
irradiation (Figure 15).
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Figure 15  X-ray-induced Caspase-3 cleavage is not perturbed in egr mutants and egr is not transcriptionally
upregulated in response to X-ray.
6.10  Further Genes Tested for Suppression of the Small Eye
Gene: Genotype: Suppression: Allele Source:
IMD: IMD-/- ; GMR-egr no suppression B. Lemaitre
dFADD: GMR-egr; dFADD-/- no suppression Naitza et al. (2002)
Toll (Tl): GMR-egr; Tl
-/- no suppression B. Lemaitre
pelle (pll): GMR-egr; pll
-/- no suppression B. Lemaitre
Relish (Rel): GMR-egr; Rel
-/- no suppression B. Lemaitre
p38a: GMR-egr; p38a
-/- no suppression Craig et al. (2004)
dMEKK1: GMR-egr; dMEKK1
-/- no suppression Inoue et al. (2001)
dMyD88: GMR-egr; dMyD88
-/- no suppression Charatsi et al. (2003)
MAPk-Ak2: MAPk-Ak2
-/Y
; GMR-egr no suppression G. Seisenbacher
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7  Materials
7.1  Fly Stocks
Balanced EMS-induced suppressor mutations:
Stocks carrying an allele on the second chromosome might have Mkrs, TM6b or y+ floating on
the third. Some still carry the GMR-Gal4(w+) insertion on the second chromosome.
Stocks carrying an allele on the third chromosome are clean for the second chromosome.
(I): genotype associated with chromosome I
(II): genotype associated with chromosome II
(III): genotype associated with chromosome III
BL: Bloomington Stock Number
Gal4 driver:
GMR-Gal4 (II) strong bK376
GMR-Gal4 (II) weak K627
GMR-Gal4 (III) weak K628
prd-Gal4 (III) bK387
wing-Gal4 (III) (C765, line 10) K369
UAS transgenes:
UAS-egr (II) strong Moreno et al. (2002b)
UAS-egr (III) weak Moreno et al. (2002b)
UAS-hep
CA (II) Adachi-Yamada et al. (1999)
EP-hid (III) -
UAS-Egfr
DN (II) MF806 (Freeman Lab)
UAS-lilli (II) Wittwer et al. (2001)
UAS-djun (II) Hafen Lab
UAS-dfos (II) BL-7213
UAS-dfos
bZIP (III) Marek Mlodzik
UAS-Inr (II) Brogiolo et al. (2001)
UAS-dgadd (II)+(III) this thesis
UAS-dTAB2 (II)+(III) this thesis
tub-dTAB2 (III) this thesis
UAS-Mkk4 (II)+(III) this thesis
tub-Mkk4 (II)+(III) this thesis
UAS-Mkk4
Asp (II)+(III) this thesis
UAS-Mkk4
Mut (II)+(III) this thesis
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Combinations of Gal4 and UAS transgenes:
GMR-Gal4 (strong) UAS-egr/CyO
GMR-Gal4 (strong) UAS-egr/CyO; Mkrs/TM6b
GMR-Gal4 (weak) UAS-egr/TM6b
Sp/CyO; GMR-Gal4 (weak) UAS-egr/TM6b
UAS-egr; prd-Gal4
GMR-Gal4 (weak) UAS-hepCA/CyO
GMR-Gal4 (weak) UAS-hepCA/CyO: Mkrs/TM6b
GMR-Gal4 (weak) EP-hid/TM6b
GMR-Gal4 (strong) UAS-EgfrDN/CyO
GMR-Gal4 (strong) UAS-Inr/CyO
Others:
UAS-egr; y
+ this thesis
Df(2R)BSC26 (II) BL-6866
Df(2L)C144 (II) BL-90
bsk
1 (II) Hafen Lab
hep
1 (I) Noselli Lab
msn
102 (III) Hafen Lab
lilli
4U5,15D1 (II) Wittwer et al. (2001)
egr
1,3 (II) Igaki et al. (2002)
dTAK1
1,2,3,4 (I) Vidal et al. (2001)
dTRAF1
ex1 (II) Cha et al. (2003)
dTRAF2
ex1 (I) Cha et al. (2003)
EP2L (II) Zipperlen et al. (2005)
FRT40 (II) Zipperlen et al. (2005)
RFP4,5,15 (III) J. Bischof
f07920 (III) Exelixis
d03195 (III) Exelixis
P[dTAK1] (III) genomic rescue transgene Vidal et al. (2001)
P[egr] (II)+(III) genomic rescue transgene (713) D. Hengartner
679-lacZ (II)+(III) egrZ this thesis
714-lacZ (II)+(III) egrZ D. Hengartner
2x714-lacZ (II) egrZ this thesis
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7.2  Constructs
pUAST-dTAB2 PCR (PG164+PG165) on EST LD40663
cloned into pMZ55 Asp718 X HindIII
cut out with Asp718(blunt) X NotI
cloned into pUAST ExoRI(blunt) X NotI
pUAST-HA-dTAB2 PCR (PG163+PG164) on EST LD40663
cloned into pMZ55 NheI X HindIII
cut out with Asp718(blunt) X NotI
cloned into pUAST ExoRI(blunt) X NotI
tub-dTAB2 PCR (PG164+PG165) on EST LD40663
cloned into pMZ55 Asp718 X HindIII
cut out with Asp718 X NotI
cloned into pOP118 Asp718 X NotI
tub-HA-dTAB2 PCR (PG163+PG164) on EST LD40663
cloned into pMZ55 NheI X HindIII
cut out with Asp718 X NotI
cloned into pOP118 Asp718 X NotI
pUAST-Mkk4 PCR (PG171+PG172) on EST RE70055
cloned into pMZ55 Asp718 X HindIII (=pMZ55-Mkk4)
cut out with Asp718(blunt) X NotI
cloned into pUAST ExoRI(blunt) X NotI
pUAST-HA-Mkk4 PCR (PG170+PG171) on EST RE70055
cloned into pMZ55 NheI X HindIII (=pMZ55-HA-Mkk4)
cut out with Asp718(blunt) X NotI
cloned into pUAST ExoRI(blunt) X NotI
tub-Mkk4 PCR (PG171+PG172) on EST RE70055
cloned into pMZ55 Asp718 X HindIII
cut out with Asp718 X NotI
cloned into pOP118 Asp718 X NotI
tub-HA-Mkk4 PCR (PG170+PG171) on EST RE70055
cloned into pMZ55 NheI X HindIII
cut out with Asp718 X NotI
cloned into pOP118 Asp718 X NotI
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pUAST-Mkk4Asp annealed primer Mkk4Asp_fw + Mkk4Asp_rev
cloned into pMZ55-Mkk4 PstI X SalI
cut out with Asp718(blunt) X NotI
cloned into pUAST EcoRI(blunt) X NotI
pUAST-HA-Mkk4Asp annealed primer Mkk4Asp_fw + Mkk4Asp_rev
cloned into pMZ55-HA-Mkk4 PstI X SalI
cut out with Asp718(blunt) X NotI
cloned into pUAST EcoRI(blunt) X NotI
pUAST-Mkk4Mut annealed primer Mkk4Mut_fw + Mkk4Mut_rev
cloned into pMZ55-Mkk4 PstI X SalI
cut out with Asp718(blunt) X NotI
cloned into pUAST EcoRI(blunt) X NotI
pUAST-HA-Mkk4Mut annealed primer Mkk4Mut_fw + Mkk4Mut_rev
cloned into pMZ55-HA-Mkk4 PstI X SalI
cut out with Asp718(blunt) X NotI
cloned into pUAST EcoRI(blunt) X NotI
pUAST-dgadd (CG11086) PCR (PG101+102) on yw DNA
cloned into pKB342 Asp718 X EcoRI
cut out with Asp718 X XbaI
cloned into pUAST Asp718 X XbaI
pDA675-pX27 cloned into pX27(XbaINotI) BamHI X NotI
pDA676-pX27 pDA676 KspI(blunt) X BamHI
cloned into pX27 EcoRI(blunt) X BamHI
pDA679-pX27 cloned into pX27(XbaIAsp718) BamHi X Asp718
pDA690-pX27 cloned into pX27 BamHI X XhoI
hidF1-pX27 PCR (PG111+PG112) on yw DNA
cloned into pX27 XbaI X EcoRI
hidF2-pX27 PCR (PG105+PG106) on yw DNA
cloned into pX27 EcoRI
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hidF3-pX27 PCR (PG107+PG108) on yw DNA
cloned into pX27 XbaI X EcoRI
hidF4-pX27 PCR (PG109+PG110) on yw DNA
cloned into pX27 XbaI
7.3  Primers
bsk sequencing:
bsk1 CCACCCATTCAGAATGGAGC
bsk2 CGGCCTTTACAACTATATTGG
bsk3 CGACAGAATGTCCTATTTGC
bsk4 CAATACACGCCGTATTGTTGG
dTAK1 sequencing:
dTAK1-f1 CAAGGAATCGGTGGCATAC
dTAK1-r1 CTGGTTATGCGGAATAGC
dTAK1-f2 GGTTATAACGTAGGGCTC
dTAK1-r2 CGAGCAGTTCAAGGATC
dTAK1-f3 GCGTTCTTTTACTCTGCC
dTAK1-r3 CCATTGTGTCTCTGAACG
dTAK1-f4 GTTCGAGGCTGTCGAAGTTC
dTAK1-r4 CGTACAGATACAGACTACG
dTAB2 sequencing:
PG153 GAACAACAGTCAGGAGCTAGC
PG154 CGCAAGGCAATCATTTGTTGC
PG155 CCATCTTCTGCTAAAACTACG
PG156 GCGTCAAAACTAACGCTGG
PG156.2 GTTGCGTACAAGGTCCTTGG
PG157 GCTTCATCCTATCCCAGTGC
PG157.2 CCAGATGTTGAGGAAGGAGC
PG158 GGGCAATGGTATAATCCCG
G867_mut GAGACACGAGGAATCGTTGG
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dTAB2 cloning and construct sequencing:
PG163 AAAAGCTAGCATGGCGGCTACACCACCAATGC
PG164 AAAAAAGCTTTTATGTATGCAGAGCGTACGGC
PG165 AAAGGTACCGCCACCATGGCGGCTACACCACCAATGC
sequencing:
PG166 CCAGATGTTGAGGAAGGAGC
PG167 GCAGCTTCTCCAACGATTCC
PG168 GTTAGTTTTGACGCACGTCG
PG169 CACTATCGAGCGTCAGAAGC
seq_HA_GAP CCTGTTTCATGAGATGAAGC
plus standard primers: tub prom, tub-1, M13
Mkk4 sequencing:
Mkk4_seq1 CGGACAAAACATCCTTAGG
Mkk4_seq2 GCATGCTGTTGTGTTCTTC
Mkk4_seq3 CAAGCTACAGTTTGGTGAGG
Mkk4_seq4 CAACATTCTGTTGCACCGTCG
Mkk4_seq5 CAAAGGAGCATCAAGTCG
Mkk4_seq6 GGTCATCTTGTTGACTGCCC
Mkk4_seq7 GAGCGCATTGATCCAGAACG
Mkk4_seq8 GGAAATTACCAGTCGCCACC
Mkk4_seq9 CTGCTTTCCTTCTGCTTAG
Mkk4 cloning and construct sequencing:
PG170 AAAAGCTAGCATGGCCGAACGACCGAAAAATTTG
PG171 AAAAAAGCTTTTAACTCTCCGCCTGCTGATTGGC
PG172 AAAGGTACCGCCACCATGGCCGAACGACCGAAAAATTTG
sequencing: Mkk4_seq3,6,7,8 and standard primers: tub prom, tub-1, M13
Mkk4
Asp
 and Mkk4
Mut
:
Mkk4Asp_fw TCGAcgatattgccaaggataaggatgcgggcTGCA
Mkk4Asp_rev gcccgcatccttatccttggcaatatcg
Mkk4Mut_fw TCGAcgctattgccaaggtcaaggatgcgggcTGCA
Mkk4Mut_rev gcccgcatccttgaccttggcaatagcg
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lilli sequencing: (oFW primers kindly provided by F. Wittwer)
lilli_seqA CCTACGTATGTGAAGCAGGC
lilli_seqB GCAGCAATAGTTCCGAGTCC
lilli_seqC CATTCTGGATTCAAGCGACG
lilli_seqD GTCAAGCTGAACAAGACTGG
lilli_seqE TGTTGCCGTTGGCAATGTCC
oFW22 CCTCGACCTTAACCCTTTGG
oFW23 AGGCAAGCCAAATGCCTCTG
oFW24 GTGACTCCGGAAGCTGCTTTG
oFW25 AAATTCAAGCCCGGCAATGTC
oFW27 ATAGTTGCTAATTTGGCCTGAC
oFW28 CGGCCATTGTTAAGAACGAG
oFW32 AGTTGCTGTTGCTGGAACTG
oFW36 CCAGCCACAAGGCTTATATAC
oFW37 CCATTCTCAGGTAGATCATTAC
oFW39 CAGCGACATAGCAAATATCTT
oFW40 TAAGCAAGCTTTCGCGAGAG
oFW41 TCATGGGACTAGGTGGTAATG
oFW47 GAAATAATGGCTTAAACCAGTAC
hid, rpr, grim, skl sequencing:
hid_ex1_fw gcaaagtgccaacaaagtgc
hid_ex1_rev cgtaagcagttattctgtgtgg
hid_ex2_fw gggtgatctttattacggg
hid_ex2_rev caggcagtgtatcttttggc
hid_ex3_fw ccgaatccgaatccgaaccg
hid_ex3_rev ggcaggcaatgaatgctaac
hid_ex4_fw tggttcggtcacgtgtgtgg
hid_ex4_rev tcgttgcacttatgtacgg
rpr_fw gaacaaagtgaacgaactcg
rpr_rev ggttttgggttggctcatgc
grim_fw ccaagtgctcgatacgaaac
grim_rev tcgttcctcctcatgtgtcc
skl_fw gaaataccttgccacacatcg
skl_rev gtctcgctcattctctctcg
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hid reporter:
PG105 (hidF2) GCgaattcGGTATGTAGTATGTTCCCC
PG106 (hidF2) GCgaattcCCTTCCTGCACTTTGTTGGC
PG107 (hidF3) GCtctagaCCACACAGAATAACTGCTTACG
PG108 (hidF3) GCgaattcGGAATTGCATTTGCGACTGG
PG109 (hidF4) GCtctagaGCTGTTGAGACGTGCAGTTTGC
PG110 (hidF4) GCtctagaGCAGAAGTACGTGTATCTTACC
PG111 (hidF1) GCtctagaGGATCTGGATCTCAATCTG
PG112 (hidF1) GCgaattcCTCGAACTCGAACTCGAACG
dgadd (CG11086) cloning:
PG101 gcggtaccaccatggtcgtcgaggagaactgc
PG102 gcgaattctacacagccggcagctggacaatgg
8  Methods
8.1  Molecular Cloning
Standard molecular biology techniques are described in Sambrook J. and Russell D.W.,
Molecular Cloning - A Laboratory Manual. (2001) Cold Spring Harbor, NY: Cold Spring
Harbor Laboratory Press.
8.2  EMS Treatment
Drosophila males were starved for 8 hours before mutagenesis. These males were then kept
for 24 hours in a bottle containing a filter paper soaked with 0.4% EMS in sugar solution
(1g/100ml). After a recovery phase of another 24 hours on normal food, the mutagenized
males were mated at 25°C with virgins.
8.3  Paraquat Treatment
For oxidative-stress challenge, flies were starved in empty vials for 6 h and then transferred to
vials containing a gel of phosphate-buffered saline (PBS), 10% sucrose, 0.8% low-melt
agarose and 20 mM paraquat. Paraquat was added to the solution after cooling down to
40°C. A control population of flies was placed in vials containing the PBS-sucrose gel without
paraquat.
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8.4  lacZ staining
To detect ß-galactosidase activity, third instar larval discs were fixed in 1% glutaraldehyd and
subjected to the following standard X-gal color reaction:
1ml Buffer B (1mM MgCl2, 10mM NaPi (Natriumphosphate-buffer pH 7), 150mM NaCl)
10µl Potassium Ferricyanide K3[Fe(CN)6] (333mM)
10µl Potassium Ferrocyanide K4[Fe(CN)6]3H2O (333mM)
5µl 10% Triton-X-100
10µl 8% X-Gal
8.5  Immunohistochemistry
Imaginal discs dissected from late third instar larvae were fixed and stained with appropriate
antibodies. The following antibodies were used: 1° rabbit polyclonal anti--galactosidase
(1/2000, Cappel), 1° rabbit polyclonal anti-cleaved-caspase-3 (1/400, Cell Signaling), 2° Alexa
Fluor 594 goat anti-rabbit (1/200, Molecular Probes).
For biochemistry and cell culture methods see Narasimamurthy (2006) and Geuking et al.
(2005).
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